Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends

Bladder cancer has become a common cancer globally, with an estimated 430 000 new cases diagnosed in 2012. We examine the most recent global bladder cancer incidence and mortality patterns and trends, the current understanding of the aetiology of the disease, and specific issues that may influence t...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	European urology Ročník 71; číslo 1; s. 96 - 108
Hlavní autoři:	Antoni, Sebastien, Ferlay, Jacques, Soerjomataram, Isabelle, Znaor, Ariana, Jemal, Ahmedin, Bray, Freddie
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Switzerland Elsevier B.V 01.01.2017
Témata:	Bladder Cancer Female Global Health - statistics & numerical data Global Health - trends Humans Incidence Internationality Male Mortality Registries Risk Factors Smoking - adverse effects Smoking - epidemiology Statistics Urinary Bladder Neoplasms - epidemiology Urinary Bladder Neoplasms - etiology Urinary Bladder Neoplasms - mortality Urology Bladder Statistics Mortality Cancer Incidence
ISSN:	0302-2838, 1873-7560
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Abstract	Bladder cancer has become a common cancer globally, with an estimated 430 000 new cases diagnosed in 2012. We examine the most recent global bladder cancer incidence and mortality patterns and trends, the current understanding of the aetiology of the disease, and specific issues that may influence the registration and reporting of bladder cancer. Global bladder cancer incidence and mortality statistics are based on data from the International Agency for Research on Cancer and the World Health Organisation (Cancer Incidence in Five Continents, GLOBOCAN, and the World Health Organisation Mortality). Bladder cancer ranks as the ninth most frequently-diagnosed cancer worldwide, with the highest incidence rates observed in men in Southern and Western Europe, North America, as well in certain countries in Northern Africa or Western Asia. Incidence rates are consistently lower in women than men, although sex differences varied greatly between countries. Diverging incidence trends were also observed by sex in many countries, with stabilising or declining rates in men but some increasing trends seen for women. Bladder cancer ranks 13th in terms of deaths ranks, with mortality rates decreasing particularly in the most developed countries; the exceptions are countries undergoing rapid economic transition, including in Central and South America, some central, southern, and eastern European countries, and the Baltic countries. The observed patterns and trends of bladder cancer incidence worldwide appear to reflect the prevalence of tobacco smoking, although infection with Schistosoma haematobium and other risk factors are major causes in selected populations. Differences in coding and registration practices need to be considered when comparing bladder cancer statistics geographically or over time. The main risk factor for bladder cancer is tobacco smoking. The observed patterns and trends of bladder cancer incidence worldwide appear to reflect the prevalence of tobacco smoking. Diverging patterns in bladder cancer are observed linked to the phase of the tobacco epidemic, and in specific countries, the prevalence of Schistosoma haematobium infection. While other factors contribute, harmonisation of registry coding of noninvasive tumours will improve international comparability.
AbstractList	Bladder cancer has become a common cancer globally, with an estimated 430 000 new cases diagnosed in 2012. We examine the most recent global bladder cancer incidence and mortality patterns and trends, the current understanding of the aetiology of the disease, and specific issues that may influence the registration and reporting of bladder cancer. Global bladder cancer incidence and mortality statistics are based on data from the International Agency for Research on Cancer and the World Health Organisation (Cancer Incidence in Five Continents, GLOBOCAN, and the World Health Organisation Mortality). Bladder cancer ranks as the ninth most frequently-diagnosed cancer worldwide, with the highest incidence rates observed in men in Southern and Western Europe, North America, as well in certain countries in Northern Africa or Western Asia. Incidence rates are consistently lower in women than men, although sex differences varied greatly between countries. Diverging incidence trends were also observed by sex in many countries, with stabilising or declining rates in men but some increasing trends seen for women. Bladder cancer ranks 13th in terms of deaths ranks, with mortality rates decreasing particularly in the most developed countries; the exceptions are countries undergoing rapid economic transition, including in Central and South America, some central, southern, and eastern European countries, and the Baltic countries. The observed patterns and trends of bladder cancer incidence worldwide appear to reflect the prevalence of tobacco smoking, although infection with Schistosoma haematobium and other risk factors are major causes in selected populations. Differences in coding and registration practices need to be considered when comparing bladder cancer statistics geographically or over time. The main risk factor for bladder cancer is tobacco smoking. The observed patterns and trends of bladder cancer incidence worldwide appear to reflect the prevalence of tobacco smoking. Diverging patterns in bladder cancer are observed linked to the phase of the tobacco epidemic, and in specific countries, the prevalence of Schistosoma haematobium infection. While other factors contribute, harmonisation of registry coding of noninvasive tumours will improve international comparability. Abstract Context Bladder cancer has become a common cancer globally, with an estimated 430 000 new cases diagnosed in 2012. Objective We examine the most recent global bladder cancer incidence and mortality patterns and trends, the current understanding of the aetiology of the disease, and specific issues that may influence the registration and reporting of bladder cancer. Evidence acquisition Global bladder cancer incidence and mortality statistics are based on data from the International Agency for Research on Cancer and the World Health Organisation (Cancer Incidence in Five Continents, GLOBOCAN, and the World Health Organisation Mortality). Evidence synthesis Bladder cancer ranks as the ninth most frequently-diagnosed cancer worldwide, with the highest incidence rates observed in men in Southern and Western Europe, North America, as well in certain countries in Northern Africa or Western Asia. Incidence rates are consistently lower in women than men, although sex differences varied greatly between countries. Diverging incidence trends were also observed by sex in many countries, with stabilising or declining rates in men but some increasing trends seen for women. Bladder cancer ranks 13th in terms of deaths ranks, with mortality rates decreasing particularly in the most developed countries; the exceptions are countries undergoing rapid economic transition, including in Central and South America, some central, southern, and eastern European countries, and the Baltic countries. Conclusions The observed patterns and trends of bladder cancer incidence worldwide appear to reflect the prevalence of tobacco smoking, although infection with Schistosoma haematobium and other risk factors are major causes in selected populations. Differences in coding and registration practices need to be considered when comparing bladder cancer statistics geographically or over time. Patient summary The main risk factor for bladder cancer is tobacco smoking. The observed patterns and trends of bladder cancer incidence worldwide appear to reflect the prevalence of tobacco smoking. CONTEXTBladder cancer has become a common cancer globally, with an estimated 430 000 new cases diagnosed in 2012.OBJECTIVEWe examine the most recent global bladder cancer incidence and mortality patterns and trends, the current understanding of the aetiology of the disease, and specific issues that may influence the registration and reporting of bladder cancer.EVIDENCE ACQUISITIONGlobal bladder cancer incidence and mortality statistics are based on data from the International Agency for Research on Cancer and the World Health Organisation (Cancer Incidence in Five Continents, GLOBOCAN, and the World Health Organisation Mortality).EVIDENCE SYNTHESISBladder cancer ranks as the ninth most frequently-diagnosed cancer worldwide, with the highest incidence rates observed in men in Southern and Western Europe, North America, as well in certain countries in Northern Africa or Western Asia. Incidence rates are consistently lower in women than men, although sex differences varied greatly between countries. Diverging incidence trends were also observed by sex in many countries, with stabilising or declining rates in men but some increasing trends seen for women. Bladder cancer ranks 13th in terms of deaths ranks, with mortality rates decreasing particularly in the most developed countries; the exceptions are countries undergoing rapid economic transition, including in Central and South America, some central, southern, and eastern European countries, and the Baltic countries.CONCLUSIONSThe observed patterns and trends of bladder cancer incidence worldwide appear to reflect the prevalence of tobacco smoking, although infection with Schistosoma haematobium and other risk factors are major causes in selected populations. Differences in coding and registration practices need to be considered when comparing bladder cancer statistics geographically or over time.PATIENT SUMMARYThe main risk factor for bladder cancer is tobacco smoking. The observed patterns and trends of bladder cancer incidence worldwide appear to reflect the prevalence of tobacco smoking. Bladder cancer has become a common cancer globally, with an estimated 430 000 new cases diagnosed in 2012. We examine the most recent global bladder cancer incidence and mortality patterns and trends, the current understanding of the aetiology of the disease, and specific issues that may influence the registration and reporting of bladder cancer. Global bladder cancer incidence and mortality statistics are based on data from the International Agency for Research on Cancer and the World Health Organisation (Cancer Incidence in Five Continents, GLOBOCAN, and the World Health Organisation Mortality). Bladder cancer ranks as the ninth most frequently-diagnosed cancer worldwide, with the highest incidence rates observed in men in Southern and Western Europe, North America, as well in certain countries in Northern Africa or Western Asia. Incidence rates are consistently lower in women than men, although sex differences varied greatly between countries. Diverging incidence trends were also observed by sex in many countries, with stabilising or declining rates in men but some increasing trends seen for women. Bladder cancer ranks 13th in terms of deaths ranks, with mortality rates decreasing particularly in the most developed countries; the exceptions are countries undergoing rapid economic transition, including in Central and South America, some central, southern, and eastern European countries, and the Baltic countries. The observed patterns and trends of bladder cancer incidence worldwide appear to reflect the prevalence of tobacco smoking, although infection with Schistosoma haematobium and other risk factors are major causes in selected populations. Differences in coding and registration practices need to be considered when comparing bladder cancer statistics geographically or over time. The main risk factor for bladder cancer is tobacco smoking. The observed patterns and trends of bladder cancer incidence worldwide appear to reflect the prevalence of tobacco smoking.
Author	Jemal, Ahmedin Znaor, Ariana Bray, Freddie Ferlay, Jacques Soerjomataram, Isabelle Antoni, Sebastien
Author_xml	– sequence: 1 givenname: Sebastien surname: Antoni fullname: Antoni, Sebastien organization: Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France – sequence: 2 givenname: Jacques surname: Ferlay fullname: Ferlay, Jacques organization: Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France – sequence: 3 givenname: Isabelle surname: Soerjomataram fullname: Soerjomataram, Isabelle organization: Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France – sequence: 4 givenname: Ariana surname: Znaor fullname: Znaor, Ariana organization: Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France – sequence: 5 givenname: Ahmedin surname: Jemal fullname: Jemal, Ahmedin organization: Surveillance and Health Services Research, American Cancer Society, Atlanta, GA, USA – sequence: 6 givenname: Freddie surname: Bray fullname: Bray, Freddie email: brayf@iarc.fr organization: Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/27370177$$D View this record in MEDLINE/PubMed
BookMark	eNqVklFrFDEUhYNU7Hb1H4jMoy-z3kxmJpkiQl1sLbYUtD6HTHIHsmaTmsxU9t-b6dY-FKQULtwbOOckfLlH5MAHj4S8pbCiQNsPmxVOcYphVeXTCnJReEEWVHBW8qaFA7IABlVZCSYOyVFKGwBgTcdekcOKMw6U8wX59tkpYzAWa-V1budeW4N5LJQ3xWWIo3J23B0XJ8WZC71yxdUtxluLf-4E31GjH4vriN6k1-TloFzCN_d9SX6efrlefy0vrs7O1ycXpa45jOUgWgGq161WQuRmKKedqSgw1Xe6N13dimFoDfYCNIVGs2aACgfT1oxTHNiSvN_n3sTwe8I0yq1NGp1THsOUJBVVy2ndVE2WvruXTv0WjbyJdqviTv4DkAX1XqBjSCni8CChIGfOciP3nOXMWUKu_NIlOX5k03ZUow1-jMq6p8yf9mbMkDLKKJO2M3NjI-pRmmCfG6Cd9VYr9wt3mDZhij5_gKQyVRLkj3kP5jWgbR4EdDng4_8Dnr7_L_CFw_E
CitedBy_id	crossref_primary_10_1007_s00292_021_00988_9 crossref_primary_10_1016_j_ajpath_2025_01_016 crossref_primary_10_1007_s00432_022_03926_1 crossref_primary_10_1177_03915603231204078 crossref_primary_10_1186_s12939_023_02084_1 crossref_primary_10_1007_s10147_023_02454_3 crossref_primary_10_1016_j_euf_2016_11_004 crossref_primary_10_3390_cells9020291 crossref_primary_10_1007_s11255_023_03727_6 crossref_primary_10_3390_ijms26115326 crossref_primary_10_1016_j_nut_2022_111868 crossref_primary_10_1038_s41598_020_58136_x crossref_primary_10_3390_cancers11091219 crossref_primary_10_1155_2019_8923780 crossref_primary_10_1016_j_clgc_2022_08_011 crossref_primary_10_1016_j_euf_2022_01_012 crossref_primary_10_1016_j_ucl_2020_10_005 crossref_primary_10_1159_000509255 crossref_primary_10_3103_S0095452724050062 crossref_primary_10_1016_j_ygeno_2021_11_028 crossref_primary_10_3892_etm_2017_4908 crossref_primary_10_1016_j_euo_2019_01_015 crossref_primary_10_3892_ol_2019_10143 crossref_primary_10_1038_s41598_018_35637_4 crossref_primary_10_1515_med_2025_1163 crossref_primary_10_1080_14656566_2020_1736036 crossref_primary_10_1136_bmjopen_2023_080092 crossref_primary_10_1016_j_euo_2018_06_002 crossref_primary_10_1155_2021_5510663 crossref_primary_10_2147_CMAR_S245233 crossref_primary_10_1007_s11255_019_02105_5 crossref_primary_10_1111_ajco_14001 crossref_primary_10_1111_ajco_13156 crossref_primary_10_1016_j_eururo_2017_03_019 crossref_primary_10_1038_s41585_023_00761_y crossref_primary_10_1186_s11658_022_00307_x crossref_primary_10_1002_jcb_27922 crossref_primary_10_1038_nrurol_2017_179 crossref_primary_10_1007_s13258_024_01523_9 crossref_primary_10_1097_MD_0000000000035722 crossref_primary_10_1186_s12885_019_6139_6 crossref_primary_10_3390_jcm10143042 crossref_primary_10_1007_s00330_019_06222_8 crossref_primary_10_1111_bju_15132 crossref_primary_10_3390_cancers10120484 crossref_primary_10_3390_genes9110552 crossref_primary_10_1155_2019_3875147 crossref_primary_10_1016_j_euo_2018_08_032 crossref_primary_10_1016_j_eururo_2020_04_023 crossref_primary_10_1155_2020_7139721 crossref_primary_10_3389_fgene_2022_1087246 crossref_primary_10_3390_cancers16132299 crossref_primary_10_1016_j_biopha_2020_110703 crossref_primary_10_1016_j_eururo_2019_08_024 crossref_primary_10_3389_fonc_2021_795242 crossref_primary_10_3390_ijms25031732 crossref_primary_10_5334_aogh_2545 crossref_primary_10_1016_j_clgc_2023_03_004 crossref_primary_10_1016_j_urolonc_2025_07_005 crossref_primary_10_1074_jbc_RA118_005621 crossref_primary_10_1016_j_ygeno_2021_04_033 crossref_primary_10_1186_s12885_020_07371_6 crossref_primary_10_1186_s12957_021_02148_y crossref_primary_10_1002_smtd_202201313 crossref_primary_10_1097_MOU_0000000000000697 crossref_primary_10_3390_cancers17040713 crossref_primary_10_1016_j_euf_2019_02_012 crossref_primary_10_1111_iju_13955 crossref_primary_10_1016_j_humpath_2018_05_005 crossref_primary_10_1016_j_ymthe_2020_09_004 crossref_primary_10_1080_01478885_2021_1924971 crossref_primary_10_1016_j_gene_2021_145451 crossref_primary_10_1016_j_clgc_2020_03_018 crossref_primary_10_1080_14786419_2022_2148246 crossref_primary_10_1186_s13046_018_0971_4 crossref_primary_10_1155_2022_1793005 crossref_primary_10_1002_jcp_27288 crossref_primary_10_1007_s12032_021_01455_4 crossref_primary_10_2147_CMAR_S326732 crossref_primary_10_1080_14656566_2017_1392510 crossref_primary_10_3389_fonc_2020_596623 crossref_primary_10_3389_fonc_2020_572672 crossref_primary_10_1016_j_annepidem_2020_05_006 crossref_primary_10_1002_cam4_4278 crossref_primary_10_1016_j_euf_2019_02_007 crossref_primary_10_4274_jus_galenos_2022_2021_0131 crossref_primary_10_3389_fonc_2019_01533 crossref_primary_10_1007_s13577_020_00343_9 crossref_primary_10_2147_OTT_S248006 crossref_primary_10_3389_fonc_2024_1412346 crossref_primary_10_1002_ijc_31650 crossref_primary_10_1038_s41598_021_91081_x crossref_primary_10_3389_fonc_2023_1196802 crossref_primary_10_1155_2020_8866730 crossref_primary_10_1016_j_gene_2019_02_070 crossref_primary_10_1038_s41388_020_1275_7 crossref_primary_10_1093_glycob_cwab083 crossref_primary_10_1016_j_canlet_2017_06_027 crossref_primary_10_1016_j_urolonc_2020_06_013 crossref_primary_10_1007_s00428_017_2064_8 crossref_primary_10_1002_mnfr_201800079 crossref_primary_10_1016_j_mehy_2020_110100 crossref_primary_10_1016_j_urolonc_2020_11_034 crossref_primary_10_1097_MD_0000000000037554 crossref_primary_10_1016_j_ejrad_2022_110666 crossref_primary_10_1016_j_clgc_2025_102306 crossref_primary_10_1038_s41585_019_0226_y crossref_primary_10_1002_gcc_22516 crossref_primary_10_1016_j_heliyon_2021_e06756 crossref_primary_10_2217_fon_2021_0110 crossref_primary_10_1016_j_clgc_2022_06_015 crossref_primary_10_1038_s41598_024_52728_7 crossref_primary_10_2196_42254 crossref_primary_10_1016_j_ctrv_2016_09_018 crossref_primary_10_1016_j_omtn_2018_10_008 crossref_primary_10_1080_1354750X_2021_1883110 crossref_primary_10_3390_genes12040550 crossref_primary_10_1186_s12894_022_01083_8 crossref_primary_10_3390_cancers11091277 crossref_primary_10_1038_s41598_020_73191_0 crossref_primary_10_1177_1073274820976665 crossref_primary_10_3892_ol_2022_13421 crossref_primary_10_1016_j_clgc_2019_07_002 crossref_primary_10_1002_cam4_3373 crossref_primary_10_1038_s41392_024_01889_y crossref_primary_10_1016_j_bbcan_2025_189327 crossref_primary_10_1186_s12885_022_10102_8 crossref_primary_10_3390_cancers15235704 crossref_primary_10_3390_biom14101304 crossref_primary_10_1097_MD_0000000000010091 crossref_primary_10_1016_j_tox_2024_153782 crossref_primary_10_1016_j_jmbbm_2025_106952 crossref_primary_10_5301_uj_5000230 crossref_primary_10_3390_mi11030249 crossref_primary_10_1002_cam4_3382 crossref_primary_10_1016_j_urolonc_2020_06_009 crossref_primary_10_1016_j_jff_2020_104203 crossref_primary_10_1016_j_pdpdt_2021_102309 crossref_primary_10_1177_03915603251319133 crossref_primary_10_3389_fonc_2022_994703 crossref_primary_10_1016_j_canlet_2023_216165 crossref_primary_10_3390_math12091281 crossref_primary_10_1186_s13045_022_01285_5 crossref_primary_10_3390_ijms18081680 crossref_primary_10_7189_jogh_13_04109 crossref_primary_10_3389_fonc_2021_643362 crossref_primary_10_1007_s11136_018_1902_8 crossref_primary_10_1155_2022_3224616 crossref_primary_10_3390_cancers11050704 crossref_primary_10_1016_j_urolonc_2022_09_024 crossref_primary_10_1158_0008_5472_CAN_18_2796 crossref_primary_10_1186_s13244_023_01569_5 crossref_primary_10_1007_s10495_024_02044_2 crossref_primary_10_1111_jcmm_14114 crossref_primary_10_3892_ol_2018_9014 crossref_primary_10_1002_2211_5463_12600 crossref_primary_10_3390_cells12151939 crossref_primary_10_1016_j_euf_2019_04_013 crossref_primary_10_1016_j_urolonc_2025_05_014 crossref_primary_10_1186_s12938_020_00834_8 crossref_primary_10_1007_s12274_021_3807_z crossref_primary_10_3390_bios12100796 crossref_primary_10_3389_fonc_2020_01643 crossref_primary_10_1007_s40134_023_00412_5 crossref_primary_10_2147_CMAR_S292863 crossref_primary_10_1016_S0007_4551_20_30278_2 crossref_primary_10_3390_life12081198 crossref_primary_10_1016_j_ejrad_2020_109486 crossref_primary_10_1097_MD_0000000000011378 crossref_primary_10_1097_PAP_0000000000000235 crossref_primary_10_1158_0008_5472_CAN_20_0977 crossref_primary_10_2217_fon_2018_0695 crossref_primary_10_1016_j_urolonc_2020_11_014 crossref_primary_10_1007_s10495_023_01898_2 crossref_primary_10_1177_15347354241233233 crossref_primary_10_1002_smll_201900936 crossref_primary_10_1002_adma_202401252 crossref_primary_10_1038_s42003_023_04501_1 crossref_primary_10_1097_WON_0000000000000574 crossref_primary_10_3389_fmed_2024_1376607 crossref_primary_10_3390_diagnostics15040492 crossref_primary_10_1002_cam4_70149 crossref_primary_10_1016_j_acuro_2022_03_007 crossref_primary_10_1038_s41598_025_14977_y crossref_primary_10_3390_ijerph18105237 crossref_primary_10_1177_1724600820935473 crossref_primary_10_3389_fimmu_2022_864156 crossref_primary_10_1080_01635581_2021_2004172 crossref_primary_10_1016_j_puhe_2024_07_027 crossref_primary_10_1007_s12672_024_01575_z crossref_primary_10_3892_mmr_2021_12451 crossref_primary_10_1159_000521829 crossref_primary_10_1186_s12885_018_4059_5 crossref_primary_10_1093_intqhc_mzae040 crossref_primary_10_1038_s41467_021_23748_y crossref_primary_10_1186_s12301_021_00199_x crossref_primary_10_2174_0113816128286229240129090915 crossref_primary_10_1016_j_cellsig_2023_110996 crossref_primary_10_1155_2018_4272064 crossref_primary_10_1186_s12894_023_01285_8 crossref_primary_10_1093_annonc_mdz296 crossref_primary_10_1016_j_prp_2023_154536 crossref_primary_10_1002_cam4_3400 crossref_primary_10_1177_17588359241301339 crossref_primary_10_3892_ijo_2017_4097 crossref_primary_10_1186_s12885_022_09419_1 crossref_primary_10_1016_j_ctrv_2018_03_007 crossref_primary_10_3390_math9040363 crossref_primary_10_1186_s13046_021_01846_5 crossref_primary_10_1038_s41416_018_0084_z crossref_primary_10_1042_BSR20181436 crossref_primary_10_1016_j_ejso_2021_04_035 crossref_primary_10_1097_MD_0000000000021930 crossref_primary_10_1089_dna_2021_0164 crossref_primary_10_3390_genes13091629 crossref_primary_10_2217_bmm_2018_0481 crossref_primary_10_3389_fmolb_2021_670409 crossref_primary_10_1016_j_snb_2024_135742 crossref_primary_10_1186_s12885_021_08687_7 crossref_primary_10_3390_cancers13123089 crossref_primary_10_1016_j_tice_2023_102096 crossref_primary_10_1002_jcla_23193 crossref_primary_10_1002_jcp_29939 crossref_primary_10_1158_0008_5472_CAN_21_1323 crossref_primary_10_1186_s12885_021_08981_4 crossref_primary_10_1080_01635581_2025_2488063 crossref_primary_10_3390_ijms20020297 crossref_primary_10_1038_bjc_2017_43 crossref_primary_10_3389_fonc_2025_1506900 crossref_primary_10_1007_s00432_023_04640_2 crossref_primary_10_1016_j_clinthera_2019_08_018 crossref_primary_10_1038_s41598_020_67443_2 crossref_primary_10_1002_jcb_28024 crossref_primary_10_1159_000520539 crossref_primary_10_1016_j_bios_2023_115915 crossref_primary_10_3892_ol_2018_9089 crossref_primary_10_1016_j_urolonc_2018_09_007 crossref_primary_10_3389_fcell_2022_915798 crossref_primary_10_1038_s41598_020_76688_w crossref_primary_10_1007_s12032_017_1029_8 crossref_primary_10_3389_fonc_2021_660273 crossref_primary_10_3389_fonc_2021_704039 crossref_primary_10_1371_journal_pone_0210635 crossref_primary_10_3390_medsci6040113 crossref_primary_10_3389_fonc_2020_00394 crossref_primary_10_1186_s13062_023_00446_x crossref_primary_10_1007_s00345_018_2250_6 crossref_primary_10_1007_s00428_019_02610_z crossref_primary_10_1007_s00761_017_0325_4 crossref_primary_10_1016_j_intimp_2020_106818 crossref_primary_10_3389_fonc_2022_1019749 crossref_primary_10_1007_s00251_021_01205_w crossref_primary_10_1186_s13046_020_01697_6 crossref_primary_10_1016_j_jrras_2024_101090 crossref_primary_10_1371_journal_pone_0275574 crossref_primary_10_1007_s10495_024_02065_x crossref_primary_10_1016_j_euo_2020_01_003 crossref_primary_10_3390_tropicalmed7110347 crossref_primary_10_1016_j_ijrobp_2023_05_028 crossref_primary_10_1080_07391102_2018_1528888 crossref_primary_10_1016_j_bbrc_2021_06_069 crossref_primary_10_1007_s13273_023_00391_w crossref_primary_10_3892_ol_2021_13106 crossref_primary_10_3389_fonc_2018_00450 crossref_primary_10_1002_ctm2_675 crossref_primary_10_1186_s12967_023_04311_3 crossref_primary_10_1080_10937404_2021_1898504 crossref_primary_10_2217_imt_2020_0261 crossref_primary_10_1016_j_ebiom_2018_03_034 crossref_primary_10_3390_cancers15030813 crossref_primary_10_1177_10732748251330696 crossref_primary_10_1002_cam4_2942 crossref_primary_10_3390_cancers16020434 crossref_primary_10_1007_s00330_018_5959_0 crossref_primary_10_1373_clinchem_2018_301341 crossref_primary_10_1016_j_clgc_2018_01_009 crossref_primary_10_1001_jamanetworkopen_2024_1215 crossref_primary_10_1097_MOU_0000000000000753 crossref_primary_10_1080_2162402X_2020_1810489 crossref_primary_10_3390_cells13070627 crossref_primary_10_1080_15384101_2021_1954758 crossref_primary_10_1093_carcin_bgz045 crossref_primary_10_3389_fnut_2022_944451 crossref_primary_10_1111_cas_15051 crossref_primary_10_1016_j_ebiom_2018_07_029 crossref_primary_10_3389_fonc_2023_1102518 crossref_primary_10_1111_ijcp_14584 crossref_primary_10_4103_pm_pm_548_19 crossref_primary_10_1016_j_radcr_2020_05_022 crossref_primary_10_1021_acs_analchem_5c02393 crossref_primary_10_1016_j_critrevonc_2022_103597 crossref_primary_10_3390_ijms19020590 crossref_primary_10_1186_s12894_025_01760_4 crossref_primary_10_3389_fonc_2021_647236 crossref_primary_10_1097_MD_0000000000040289 crossref_primary_10_1093_ajcp_aqz165 crossref_primary_10_2478_acph_2023_0016 crossref_primary_10_1111_ecc_13571 crossref_primary_10_1200_EDBK_237451 crossref_primary_10_1111_iju_14854 crossref_primary_10_1080_14737140_2019_1671190 crossref_primary_10_1007_s00345_019_02697_8 crossref_primary_10_1007_s11255_019_02197_z crossref_primary_10_4103_IJPM_IJPM_692_18 crossref_primary_10_1002_cbdv_201900334 crossref_primary_10_1016_j_semcancer_2020_11_014 crossref_primary_10_3389_fonc_2024_1332148 crossref_primary_10_1007_s11912_022_01219_x crossref_primary_10_1016_j_canlet_2025_217676 crossref_primary_10_3390_jcm12134259 crossref_primary_10_4103_ua_ua_117_22 crossref_primary_10_1007_s00261_021_03091_y crossref_primary_10_1245_s10434_023_13565_6 crossref_primary_10_3389_fonc_2021_698856 crossref_primary_10_1186_s12943_019_1025_z crossref_primary_10_3389_fimmu_2021_724541 crossref_primary_10_3389_fcell_2022_725024 crossref_primary_10_1111_iju_13517 crossref_primary_10_1016_j_biopha_2018_08_107 crossref_primary_10_1097_MD_0000000000034828 crossref_primary_10_1186_s12894_023_01326_2 crossref_primary_10_1016_j_jtemb_2017_12_010 crossref_primary_10_1007_s00345_021_03721_6 crossref_primary_10_1097_JU9_0000000000000132 crossref_primary_10_1038_s41598_025_08634_7 crossref_primary_10_1002_path_5230 crossref_primary_10_3892_or_2021_8244 crossref_primary_10_1186_s40644_020_00304_3 crossref_primary_10_1038_s41598_024_68474_9 crossref_primary_10_1093_carcin_bgz039 crossref_primary_10_1002_jcp_28208 crossref_primary_10_1016_j_gene_2018_09_005 crossref_primary_10_1186_s12301_024_00453_y crossref_primary_10_2147_IJN_S354590 crossref_primary_10_3390_cancers12123661 crossref_primary_10_1186_s13000_019_0868_3 crossref_primary_10_1016_j_ajur_2025_07_002 crossref_primary_10_1007_s13402_022_00710_8 crossref_primary_10_1038_cddis_2017_331 crossref_primary_10_5124_jkma_25_0063 crossref_primary_10_1038_s41598_023_46977_1 crossref_primary_10_1002_ctm2_241 crossref_primary_10_1186_s12935_020_01345_1 crossref_primary_10_1007_s11655_022_3464_4 crossref_primary_10_1038_s41419_020_03240_z crossref_primary_10_1016_j_clgc_2019_10_008 crossref_primary_10_1016_j_jchromb_2021_122629 crossref_primary_10_1007_s10565_021_09668_z crossref_primary_10_1016_j_cmi_2018_04_003 crossref_primary_10_1002_ddr_22005 crossref_primary_10_1016_j_fertnstert_2016_12_008 crossref_primary_10_3390_jpm11100947 crossref_primary_10_3390_cells11193074 crossref_primary_10_3389_fphar_2020_00605 crossref_primary_10_1002_path_5250 crossref_primary_10_1016_j_urolonc_2022_03_004 crossref_primary_10_1007_s12210_025_01310_y crossref_primary_10_1038_s41598_025_95684_6 crossref_primary_10_1038_s41401_018_0205_5 crossref_primary_10_1016_j_tranon_2017_01_013 crossref_primary_10_1080_01635581_2021_1965630 crossref_primary_10_1016_j_jorganchem_2025_123597 crossref_primary_10_3389_fphar_2023_1280428 crossref_primary_10_1016_j_urology_2021_08_071 crossref_primary_10_3389_fonc_2025_1630726 crossref_primary_10_3389_fnut_2021_669630 crossref_primary_10_4103_cjp_cjp_110_20 crossref_primary_10_1002_jemt_23805 crossref_primary_10_1111_ijcp_14526 crossref_primary_10_3390_jcm10245969 crossref_primary_10_1002_cam4_5191 crossref_primary_10_1007_s00018_024_05236_w crossref_primary_10_1089_cbr_2019_3382 crossref_primary_10_1097_MD_0000000000028125 crossref_primary_10_4103_jcrt_JCRT_891_19 crossref_primary_10_1097_MOU_0000000000000737 crossref_primary_10_1007_s00345_022_03971_y crossref_primary_10_1186_s13062_025_00599_x crossref_primary_10_1002_path_5274 crossref_primary_10_1177_1756287219833056 crossref_primary_10_3389_fgene_2022_1100317 crossref_primary_10_1016_j_acuroe_2024_05_002 crossref_primary_10_1186_s40249_022_00980_2 crossref_primary_10_1159_000510137 crossref_primary_10_2147_CMAR_S467817 crossref_primary_10_1016_j_annepidem_2019_03_014 crossref_primary_10_1016_j_ctarc_2019_100124 crossref_primary_10_1016_j_compbiolchem_2021_107510 crossref_primary_10_1111_cas_15207 crossref_primary_10_1177_1010428317718414 crossref_primary_10_1002_cyto_a_24313 crossref_primary_10_1007_s00330_025_11773_0 crossref_primary_10_3390_cancers12040870 crossref_primary_10_1007_s12011_022_03545_4 crossref_primary_10_1016_j_gene_2020_145224 crossref_primary_10_1038_s41598_020_73370_z crossref_primary_10_1136_bmjgh_2020_004128 crossref_primary_10_1016_j_canep_2019_02_011 crossref_primary_10_3892_ol_2020_11475 crossref_primary_10_1089_end_2019_0226 crossref_primary_10_1007_s13577_021_00659_0 crossref_primary_10_1016_j_lfs_2020_118311 crossref_primary_10_1016_j_matchemphys_2022_126456 crossref_primary_10_1080_21655979_2021_1974646 crossref_primary_10_1038_s41585_019_0184_4 crossref_primary_10_3389_fonc_2022_915171 crossref_primary_10_1007_s12011_022_03510_1 crossref_primary_10_1016_j_colsurfb_2020_110832 crossref_primary_10_3390_nano8050283 crossref_primary_10_1016_j_ijsu_2020_01_128 crossref_primary_10_1007_s00261_024_04245_4 crossref_primary_10_3390_pr9122136 crossref_primary_10_1016_j_omtn_2019_11_007 crossref_primary_10_3390_cancers15143683 crossref_primary_10_1007_s11596_017_1822_9 crossref_primary_10_1038_s41388_021_02019_6 crossref_primary_10_3389_fonc_2022_999203 crossref_primary_10_3389_fcell_2021_704683 crossref_primary_10_1007_s40336_018_0284_9 crossref_primary_10_3389_fonc_2021_795548 crossref_primary_10_1016_j_phymed_2021_153587 crossref_primary_10_33920_med_15_2504_01 crossref_primary_10_1155_2022_6785956 crossref_primary_10_1002_cncy_22539 crossref_primary_10_6061_clinics_2020_e1639 crossref_primary_10_3390_pharmaceutics15122688 crossref_primary_10_1016_j_acuro_2024_01_013 crossref_primary_10_2147_CMAR_S261809 crossref_primary_10_1007_s00261_024_04748_0 crossref_primary_10_3390_medicina55060302 crossref_primary_10_1016_j_intimp_2020_107146 crossref_primary_10_3389_fpubh_2023_1267534 crossref_primary_10_2217_fon_2021_0841 crossref_primary_10_1016_j_eururo_2018_06_024 crossref_primary_10_1186_s12943_019_1040_0 crossref_primary_10_3390_cancers15030580 crossref_primary_10_1016_j_prp_2019_152663 crossref_primary_10_1002_advs_202303230 crossref_primary_10_1016_j_acra_2022_04_014 crossref_primary_10_1007_s10653_024_02149_2 crossref_primary_10_1016_j_ygyno_2017_10_021 crossref_primary_10_1016_j_biopha_2020_109830 crossref_primary_10_3390_jcm11040930 crossref_primary_10_1002_smm2_1276 crossref_primary_10_1038_s41392_022_01003_0 crossref_primary_10_1177_03000605211049946 crossref_primary_10_3389_fonc_2021_655000 crossref_primary_10_1111_jcmm_14878 crossref_primary_10_3389_fimmu_2021_684879 crossref_primary_10_1111_bcp_15504 crossref_primary_10_1016_j_genrep_2019_100491 crossref_primary_10_1016_j_anndiagpath_2021_151847 crossref_primary_10_1093_ije_dyz264 crossref_primary_10_1097_MD_0000000000032558 crossref_primary_10_1007_s00345_018_2369_5 crossref_primary_10_1111_bju_15038 crossref_primary_10_1002_jcp_31412 crossref_primary_10_1002_cam4_5475 crossref_primary_10_1016_j_bulcan_2018_08_004 crossref_primary_10_1016_j_bulcan_2022_05_003 crossref_primary_10_3390_molecules27030731 crossref_primary_10_2188_jea_JE20220085 crossref_primary_10_1002_bco2_365 crossref_primary_10_1016_j_jviscsurg_2022_05_003 crossref_primary_10_62546_3034_1477_2024_2_4_27_34 crossref_primary_10_1007_s11033_021_06951_4 crossref_primary_10_1186_s13046_020_01624_9 crossref_primary_10_3389_fonc_2021_683951 crossref_primary_10_1016_j_eimce_2023_07_003 crossref_primary_10_1093_carcin_bgy140 crossref_primary_10_3389_pore_2022_1610267 crossref_primary_10_1038_s41379_021_00955_y crossref_primary_10_1111_iju_13824 crossref_primary_10_1016_j_humpath_2019_07_002 crossref_primary_10_1016_j_jnci_2018_08_001 crossref_primary_10_1016_j_canlet_2023_216246 crossref_primary_10_1177_03915603231151738 crossref_primary_10_1136_jitc_2021_004325 crossref_primary_10_1002_cam4_2385 crossref_primary_10_1111_jcmm_15750 crossref_primary_10_1038_s41598_017_11291_0 crossref_primary_10_1002_jcb_28746 crossref_primary_10_1186_s12943_019_1084_1 crossref_primary_10_1007_s11033_020_05415_5 crossref_primary_10_3389_fsurg_2023_1276746 crossref_primary_10_5114_aoms_203474 crossref_primary_10_1038_s41420_022_01037_x crossref_primary_10_3390_ijms26093959 crossref_primary_10_2188_jea_JE20200416 crossref_primary_10_3389_fpubh_2022_837854 crossref_primary_10_3390_math12223580 crossref_primary_10_1007_s11255_022_03200_w crossref_primary_10_1016_j_ecoenv_2021_112420 crossref_primary_10_1016_j_micron_2021_103152 crossref_primary_10_1038_s41598_020_79176_3 crossref_primary_10_3390_ijms22062832 crossref_primary_10_1016_j_urolonc_2019_03_008 crossref_primary_10_3390_ijms20040980 crossref_primary_10_1097_CEJ_0000000000000594 crossref_primary_10_1007_s10517_023_05732_2 crossref_primary_10_1016_j_cellsig_2021_109932 crossref_primary_10_1080_15321819_2020_1845726 crossref_primary_10_3390_ph13110329 crossref_primary_10_1111_bju_15007 crossref_primary_10_1016_j_jpha_2024_101095 crossref_primary_10_4103_ijc_ijc_644_21 crossref_primary_10_1080_0284186X_2020_1723164 crossref_primary_10_1080_07357907_2022_2028805 crossref_primary_10_1038_s41598_023_42495_2 crossref_primary_10_1016_j_ctrv_2019_04_002 crossref_primary_10_3892_mco_2021_2469 crossref_primary_10_1002_cam4_3263 crossref_primary_10_1002_jcb_26556 crossref_primary_10_1097_PAI_0000000000000957 crossref_primary_10_1177_10668969211027264 crossref_primary_10_3389_fgene_2022_1027909 crossref_primary_10_2217_fon_2021_0443 crossref_primary_10_3389_fcell_2021_641432 crossref_primary_10_3389_fsurg_2021_583806 crossref_primary_10_1002_mp_13240 crossref_primary_10_7717_peerj_12724 crossref_primary_10_1111_jcmm_17979 crossref_primary_10_1155_2019_1093815 crossref_primary_10_3389_fonc_2021_701298 crossref_primary_10_1016_j_euros_2024_02_010 crossref_primary_10_3892_mmr_2018_9527 crossref_primary_10_1016_j_jchirv_2022_03_005 crossref_primary_10_1007_s00428_017_2119_x crossref_primary_10_3390_molecules23092157 crossref_primary_10_3892_mco_2021_2415 crossref_primary_10_3892_etm_2019_8006 crossref_primary_10_1186_s12885_022_09467_7 crossref_primary_10_1038_s41388_019_1120_z crossref_primary_10_1158_2326_6066_CIR_18_0046 crossref_primary_10_1016_j_urolonc_2021_07_005 crossref_primary_10_1017_cts_2024_493 crossref_primary_10_1186_s12885_025_14132_w crossref_primary_10_1016_j_mpsur_2022_08_003 crossref_primary_10_1186_s12885_021_08350_1 crossref_primary_10_1007_s13402_020_00500_0 crossref_primary_10_1089_dna_2017_3785 crossref_primary_10_1111_1756_185X_14862 crossref_primary_10_1111_ajco_13059 crossref_primary_10_1038_s41572_023_00468_9 crossref_primary_10_1177_0963689720965178 crossref_primary_10_3389_fonc_2021_717622 crossref_primary_10_3390_jcm11175233 crossref_primary_10_1158_1078_0432_CCR_19_1635 crossref_primary_10_1007_s00432_023_05355_0 crossref_primary_10_1007_s10552_018_1046_8 crossref_primary_10_1038_s41598_024_66870_9 crossref_primary_10_1038_s41419_021_03947_7 crossref_primary_10_1016_j_cbi_2023_110725 crossref_primary_10_1097_MD_0000000000021059 crossref_primary_10_3389_fchem_2021_765552 crossref_primary_10_1016_j_eururo_2018_04_029 crossref_primary_10_3390_ijms21030829 crossref_primary_10_3389_fphar_2020_01222 crossref_primary_10_1371_journal_pntd_0007238 crossref_primary_10_1038_s41419_024_07044_3 crossref_primary_10_3390_diagnostics11122194 crossref_primary_10_1002_jbt_22674 crossref_primary_10_1186_s40001_024_01688_9 crossref_primary_10_1042_BSR20203944 crossref_primary_10_1186_s12894_021_00946_w crossref_primary_10_1016_j_critrevonc_2019_06_010 crossref_primary_10_3390_ijms22073510 crossref_primary_10_3389_fonc_2025_1554819 crossref_primary_10_3389_fonc_2020_00653 crossref_primary_10_1186_s12894_023_01211_y crossref_primary_10_1111_bju_14525 crossref_primary_10_1136_bmjopen_2017_020500 crossref_primary_10_1371_journal_pone_0307024 crossref_primary_10_1080_14737140_2018_1443812 crossref_primary_10_1155_2020_3035624 crossref_primary_10_1002_cam4_1570 crossref_primary_10_3390_diagnostics11050863 crossref_primary_10_1097_MD_0000000000036063 crossref_primary_10_1097_CU9_0000000000000009 crossref_primary_10_1093_annonc_mdz179 crossref_primary_10_1038_s41388_019_1092_z crossref_primary_10_1002_prm2_12119 crossref_primary_10_1038_s41388_021_01693_w crossref_primary_10_1016_j_jcpo_2019_100207 crossref_primary_10_1007_s13721_024_00460_7 crossref_primary_10_2147_BTT_S290311 crossref_primary_10_1016_j_micron_2020_102888 crossref_primary_10_1007_s10552_019_01191_1 crossref_primary_10_1148_radiol_220028 crossref_primary_10_3389_fphar_2018_00366 crossref_primary_10_1002_jmri_26327 crossref_primary_10_1016_j_ejca_2025_115621 crossref_primary_10_1016_j_metabol_2025_156289 crossref_primary_10_1186_s12894_019_0507_z crossref_primary_10_1002_prm2_12100 crossref_primary_10_1080_17425255_2021_1839412 crossref_primary_10_1097_CEJ_0000000000000639 crossref_primary_10_1038_s41585_022_00608_y crossref_primary_10_1186_s12951_020_00686_3 crossref_primary_10_17269_s41997_019_00227_y crossref_primary_10_1136_jitc_2020_000978 crossref_primary_10_1042_BSR20180475 crossref_primary_10_1186_s13293_020_00291_x crossref_primary_10_1016_j_urolonc_2019_05_003 crossref_primary_10_3322_caac_21834 crossref_primary_10_1016_j_urolonc_2019_05_005 crossref_primary_10_3390_ani12111455 crossref_primary_10_3390_cancers14194740 crossref_primary_10_7759_cureus_68143 crossref_primary_10_1016_j_ctrv_2017_01_007 crossref_primary_10_1002_ijc_33359 crossref_primary_10_2478_raon_2020_0072 crossref_primary_10_1089_gtmb_2020_0079 crossref_primary_10_1148_radiol_221376 crossref_primary_10_1177_11786469211065612 crossref_primary_10_1186_s12894_021_00852_1 crossref_primary_10_1016_j_bbrc_2022_07_007 crossref_primary_10_1097_CU9_0000000000000011 crossref_primary_10_1186_s12885_019_5267_3 crossref_primary_10_3389_fphys_2018_00652 crossref_primary_10_1016_j_urolonc_2018_12_026 crossref_primary_10_1002_jmri_27676 crossref_primary_10_3389_fgene_2022_798632 crossref_primary_10_1038_s41598_018_35903_5 crossref_primary_10_1097_MPA_0000000000001230 crossref_primary_10_1016_j_clgc_2020_07_005 crossref_primary_10_1016_j_compbiomed_2021_104932 crossref_primary_10_1111_cbdd_14207 crossref_primary_10_1016_j_pdpdt_2020_101719 crossref_primary_10_1016_j_fitote_2023_105791 crossref_primary_10_1186_s40824_022_00251_z crossref_primary_10_1016_j_scitotenv_2019_03_290 crossref_primary_10_1016_j_intimp_2025_114119 crossref_primary_10_3389_fsurg_2024_1489832 crossref_primary_10_1186_s12935_020_01627_8 crossref_primary_10_1097_MD_0000000000023179 crossref_primary_10_1158_0008_5472_CAN_17_2528 crossref_primary_10_1097_MD_0000000000017725 crossref_primary_10_1200_GO_21_00104 crossref_primary_10_3389_fphar_2022_837754 crossref_primary_10_3390_genes12071044 crossref_primary_10_3390_ijms24119258 crossref_primary_10_1002_ijc_33374 crossref_primary_10_1186_s13046_023_02614_3 crossref_primary_10_1016_j_biopha_2020_110393 crossref_primary_10_3390_ijms18081616 crossref_primary_10_1016_j_euf_2017_10_004 crossref_primary_10_1016_j_eururo_2019_03_044 crossref_primary_10_3390_cancers17091477 crossref_primary_10_1007_s10147_024_02575_3 crossref_primary_10_3389_fsurg_2021_636791 crossref_primary_10_3389_fgene_2021_663982 crossref_primary_10_3389_fonc_2025_1611007 crossref_primary_10_1016_j_molimm_2021_06_012 crossref_primary_10_1007_s12013_024_01492_6 crossref_primary_10_1007_s10895_023_03169_4 crossref_primary_10_3390_cancers15020359 crossref_primary_10_1002_onco_13727 crossref_primary_10_2147_RRU_S326249 crossref_primary_10_1016_S0140_6736_22_01188_6 crossref_primary_10_1007_s12672_023_00689_0 crossref_primary_10_1002_jbt_22275 crossref_primary_10_3389_fmolb_2021_631152 crossref_primary_10_3389_fonc_2021_677605 crossref_primary_10_1002_ctm2_310 crossref_primary_10_2147_OTT_S281713 crossref_primary_10_1016_j_critrevonc_2019_08_005 crossref_primary_10_1007_s00345_019_02902_8 crossref_primary_10_1080_14737159_2019_1665509 crossref_primary_10_1007_s10552_025_02044_w crossref_primary_10_1038_s41430_021_00971_w crossref_primary_10_1002_cam4_1979 crossref_primary_10_1016_j_ejrad_2024_111868 crossref_primary_10_3390_ph16101338 crossref_primary_10_1111_jcmm_16284 crossref_primary_10_3390_ijms20133162 crossref_primary_10_3390_ijms19102999 crossref_primary_10_1186_s12967_023_04118_2 crossref_primary_10_1111_bju_14915 crossref_primary_10_1007_s12195_018_0523_1 crossref_primary_10_1002_jcb_29285 crossref_primary_10_1016_j_ijbiomac_2024_139275 crossref_primary_10_3389_fmolb_2021_692941 crossref_primary_10_1080_14737159_2020_1743688 crossref_primary_10_1007_s11596_022_2580_x crossref_primary_10_1159_000527873 crossref_primary_10_3389_fendo_2022_989030 crossref_primary_10_1007_s00432_019_03028_5 crossref_primary_10_1002_em_22297 crossref_primary_10_1016_j_urolonc_2018_12_009 crossref_primary_10_1038_s41598_018_19531_7 crossref_primary_10_1021_acssensors_4c02996 crossref_primary_10_1134_S1560090418060106 crossref_primary_10_1002_bco2_438 crossref_primary_10_1172_JCI186648 crossref_primary_10_3390_medicina57080749 crossref_primary_10_3389_fpubh_2021_675927 crossref_primary_10_3389_fnut_2025_1598043 crossref_primary_10_3390_cancers16040746 crossref_primary_10_3390_ijms21082825 crossref_primary_10_1007_s00330_020_06893_8 crossref_primary_10_12677_acm_2025_1571987 crossref_primary_10_1080_17425255_2017_1341490 crossref_primary_10_1186_s13046_020_01592_0 crossref_primary_10_1016_j_ejrad_2021_110059 crossref_primary_10_1016_j_urolonc_2018_12_023 crossref_primary_10_1007_s11701_025_02379_1 crossref_primary_10_1016_j_jasc_2020_08_003 crossref_primary_10_3389_fonc_2024_1470457 crossref_primary_10_3390_cancers15123103 crossref_primary_10_1016_j_chempr_2020_06_013 crossref_primary_10_1097_CU9_0000000000000098 crossref_primary_10_1016_j_ebiom_2019_05_004 crossref_primary_10_1016_j_jgo_2023_101627 crossref_primary_10_2217_fon_2017_0433 crossref_primary_10_1016_j_clgc_2019_04_014 crossref_primary_10_3390_cancers12020307 crossref_primary_10_1371_journal_pone_0239338 crossref_primary_10_2147_OTT_S237174 crossref_primary_10_1016_j_urology_2019_03_023 crossref_primary_10_3390_molecules25173958 crossref_primary_10_1016_j_ebiom_2019_07_068 crossref_primary_10_1038_s41416_018_0320_6 crossref_primary_10_1186_s13062_023_00414_5 crossref_primary_10_1177_0963689720985113 crossref_primary_10_1016_j_clgc_2019_04_011 crossref_primary_10_1177_1758835919841235 crossref_primary_10_1016_j_molstruc_2021_131634 crossref_primary_10_1080_07853890_2021_1991591 crossref_primary_10_1007_s00345_022_04188_9 crossref_primary_10_1186_s12885_018_4530_3 crossref_primary_10_1007_s11427_020_1768_y crossref_primary_10_3389_fgene_2022_952369 crossref_primary_10_1093_jjco_hyac095 crossref_primary_10_1097_MOU_0000000000000602 crossref_primary_10_1007_s00345_018_2462_9 crossref_primary_10_1016_j_cellsig_2021_110044 crossref_primary_10_3390_cells10010080 crossref_primary_10_1007_s00345_019_02728_4 crossref_primary_10_3390_ijms22084188 crossref_primary_10_1007_s00120_022_01880_x crossref_primary_10_1016_j_lfs_2024_122821 crossref_primary_10_3389_fimmu_2025_1580315 crossref_primary_10_3390_medicina61030379 crossref_primary_10_1038_s41430_019_0453_6 crossref_primary_10_1038_s41585_025_01077_9 crossref_primary_10_1159_000507828 crossref_primary_10_1007_s13534_025_00489_1 crossref_primary_10_1186_s12935_020_01235_6 crossref_primary_10_1186_s12894_024_01459_y crossref_primary_10_1089_dna_2021_0240 crossref_primary_10_1002_1878_0261_12697 crossref_primary_10_1016_j_acuro_2020_10_004 crossref_primary_10_1016_j_euo_2021_05_005 crossref_primary_10_1002_jcp_27440 crossref_primary_10_3390_cancers15051455 crossref_primary_10_1186_s12894_020_00733_z crossref_primary_10_3389_fimmu_2022_903297 crossref_primary_10_1016_j_canep_2020_101692 crossref_primary_10_1186_s12894_022_01141_1 crossref_primary_10_1016_j_bbrc_2024_150701 crossref_primary_10_1186_s12894_024_01677_4 crossref_primary_10_1080_14786419_2022_2151007 crossref_primary_10_3233_BLC_180185 crossref_primary_10_1155_2022_3015818 crossref_primary_10_24060_2076_3093_2022_12_3_205_216 crossref_primary_10_3390_cancers15072069 crossref_primary_10_1088_1757_899X_1136_1_012046 crossref_primary_10_1016_j_modpat_2024_100631 crossref_primary_10_1038_s41598_019_50891_w crossref_primary_10_3389_fgene_2020_00180 crossref_primary_10_3390_ijms20194946 crossref_primary_10_1007_s12094_020_02330_w crossref_primary_10_1016_j_cca_2017_12_009 crossref_primary_10_3390_cancers15235551 crossref_primary_10_1038_s41590_025_02126_6 crossref_primary_10_1007_s00120_021_01737_9 crossref_primary_10_1016_j_gene_2018_08_036 crossref_primary_10_2217_fon_2021_0781 crossref_primary_10_3892_mmr_2019_10023 crossref_primary_10_2217_bmm_2020_0316 crossref_primary_10_3390_cancers13215440 crossref_primary_10_3390_cells9010235 crossref_primary_10_3389_fcell_2022_818416 crossref_primary_10_1016_j_anndiagpath_2022_152081 crossref_primary_10_1038_s41419_020_02935_7 crossref_primary_10_1089_end_2020_0112 crossref_primary_10_1002_1878_0261_12532 crossref_primary_10_1016_j_freeradbiomed_2024_11_001 crossref_primary_10_1038_s41598_019_51889_0 crossref_primary_10_2217_imt_2021_0324 crossref_primary_10_1007_s12672_025_02389_3 crossref_primary_10_1016_j_phrs_2023_106654 crossref_primary_10_1016_j_euf_2019_10_015 crossref_primary_10_1016_j_urology_2021_01_009 crossref_primary_10_1016_j_omtn_2021_01_010 crossref_primary_10_1186_s12967_021_02865_8 crossref_primary_10_1158_1940_6207_CAPR_21_0490 crossref_primary_10_3390_cancers14215286 crossref_primary_10_1186_s12957_021_02231_4 crossref_primary_10_1016_j_annemergmed_2019_03_005 crossref_primary_10_1002_cam4_4071 crossref_primary_10_3389_fphar_2023_1215296 crossref_primary_10_3892_ol_2018_9672 crossref_primary_10_1038_s41416_019_0397_6 crossref_primary_10_1136_rapm_2018_000001 crossref_primary_10_3389_fonc_2019_00889 crossref_primary_10_34172_apb_2024_035 crossref_primary_10_3389_fimmu_2024_1507355 crossref_primary_10_1002_jbio_201800016 crossref_primary_10_1016_j_urology_2020_06_009 crossref_primary_10_1080_1061186X_2017_1306535 crossref_primary_10_1089_dna_2020_5469 crossref_primary_10_1186_s12935_019_0758_5 crossref_primary_10_3390_ijms21207726 crossref_primary_10_1186_s12885_023_11383_3 crossref_primary_10_1007_s13577_019_00255_3 crossref_primary_10_1039_D5TB00546A crossref_primary_10_2217_pgs_2017_0055 crossref_primary_10_1186_s12964_020_00625_7 crossref_primary_10_1186_s12885_019_6346_1 crossref_primary_10_1038_s41698_024_00725_4 crossref_primary_10_2217_fon_2017_0284 crossref_primary_10_1155_2021_7178414 crossref_primary_10_3389_fonc_2024_1337186 crossref_primary_10_3390_cancers13184618 crossref_primary_10_3390_math11194118 crossref_primary_10_7717_peerj_18530 crossref_primary_10_1007_s00120_016_0305_0 crossref_primary_10_1080_15384101_2017_1338220 crossref_primary_10_1111_bju_15389 crossref_primary_10_5498_wjp_v14_i6_822 crossref_primary_10_1016_j_ejphar_2020_173226 crossref_primary_10_1038_s41391_019_0178_6 crossref_primary_10_1200_GO_23_00244 crossref_primary_10_1134_S1607672921020162 crossref_primary_10_17650_1726_9776_2025_21_2_68_73 crossref_primary_10_1002_1878_0261_12523 crossref_primary_10_1002_jmv_29088 crossref_primary_10_3389_fimmu_2022_970931 crossref_primary_10_3892_ol_2018_9617 crossref_primary_10_1016_j_bbcan_2018_06_002 crossref_primary_10_1097_CAD_0000000000000563 crossref_primary_10_1186_s12943_018_0908_8 crossref_primary_10_1186_s12943_019_0951_0 crossref_primary_10_1186_s12967_017_1309_2 crossref_primary_10_3389_fgene_2021_574196 crossref_primary_10_1097_JS9_0000000000001999 crossref_primary_10_1097_JS9_0000000000001516 crossref_primary_10_1016_j_afju_2018_07_003 crossref_primary_10_1016_j_foodres_2022_111144 crossref_primary_10_1038_s41388_025_03460_7 crossref_primary_10_1002_cam4_6219 crossref_primary_10_3389_fimmu_2025_1518144 crossref_primary_10_3389_fonc_2021_760389 crossref_primary_10_3390_app10207102 crossref_primary_10_3389_fcell_2021_809620 crossref_primary_10_1002_ijc_32749 crossref_primary_10_1002_jmri_29184 crossref_primary_10_1016_j_clgc_2017_03_003 crossref_primary_10_1186_s12885_025_14273_y crossref_primary_10_3390_cancers12061449 crossref_primary_10_1371_journal_pone_0188093 crossref_primary_10_3892_or_2024_8843 crossref_primary_10_1016_j_respe_2021_01_004 crossref_primary_10_1186_s12939_023_01885_8 crossref_primary_10_1186_s12967_021_03173_x crossref_primary_10_1016_j_ijrobp_2019_06_2541 crossref_primary_10_1111_bju_15336 crossref_primary_10_14701_ahbps_2021_25_3_440 crossref_primary_10_1002_adma_202203224 crossref_primary_10_2174_1381612829666230809094251 crossref_primary_10_1111_cas_14878 crossref_primary_10_1002_cam4_4443 crossref_primary_10_1111_jpi_12536 crossref_primary_10_1002_jcb_28622 crossref_primary_10_4103_ua_ua_50_23 crossref_primary_10_3390_jcm10235472 crossref_primary_10_3389_fonc_2021_641385 crossref_primary_10_1016_j_acra_2024_02_047 crossref_primary_10_3390_jcm9010209 crossref_primary_10_3389_fsurg_2022_879774 crossref_primary_10_1111_bju_14019 crossref_primary_10_1158_0008_5472_CAN_21_2362 crossref_primary_10_3390_ijms25105490 crossref_primary_10_3892_mmr_2024_13415 crossref_primary_10_1016_j_asjsur_2023_06_074 crossref_primary_10_1093_oncolo_oyaf071 crossref_primary_10_3389_fonc_2021_762946 crossref_primary_10_2196_43345 crossref_primary_10_1177_1724600820907605 crossref_primary_10_1016_j_heliyon_2024_e31587 crossref_primary_10_36303_AUJ_0105 crossref_primary_10_3892_ijo_2018_4423 crossref_primary_10_1080_1354750X_2021_1999502 crossref_primary_10_3389_fonc_2021_682710 crossref_primary_10_3390_cancers13010131 crossref_primary_10_1080_14796694_2025_2516901 crossref_primary_10_1111_cas_13565 crossref_primary_10_1002_cam4_5316 crossref_primary_10_1186_s12894_023_01354_y crossref_primary_10_4081_ejh_2021_3242 crossref_primary_10_3390_electronics11203347 crossref_primary_10_1016_j_euo_2022_10_003 crossref_primary_10_1080_14737140_2020_1736565 crossref_primary_10_1016_j_ejca_2018_03_001 crossref_primary_10_1002_cam4_3147 crossref_primary_10_3390_cancers12061400 crossref_primary_10_1016_j_canlet_2024_216613 crossref_primary_10_1002_jmri_27807 crossref_primary_10_3390_biomedicines11113064 crossref_primary_10_1007_s12010_022_04266_z crossref_primary_10_1007_s12013_025_01794_3 crossref_primary_10_1016_j_jlb_2025_100310 crossref_primary_10_3390_cancers13184673 crossref_primary_10_1002_adma_202505231 crossref_primary_10_3389_fmolb_2020_598599 crossref_primary_10_1186_s12885_019_6244_6 crossref_primary_10_1016_j_jconrel_2019_02_041 crossref_primary_10_1038_s41598_018_29187_y crossref_primary_10_1038_s41598_025_93094_2 crossref_primary_10_5812_ircmj_42071 crossref_primary_10_3390_clinpract14060201 crossref_primary_10_1016_j_trsl_2018_03_004 crossref_primary_10_1109_JTEHM_2020_3004743 crossref_primary_10_3389_fonc_2022_1018285 crossref_primary_10_1007_s00345_020_03092_4 crossref_primary_10_1088_2515_7647_ad8613 crossref_primary_10_3390_cancers13174411 crossref_primary_10_1016_j_acuroe_2022_12_003 crossref_primary_10_1096_fj_201902626R crossref_primary_10_3389_fonc_2022_835074 crossref_primary_10_1111_jcmm_17863 crossref_primary_10_1016_j_heliyon_2023_e21058 crossref_primary_10_1002_cam4_3560 crossref_primary_10_1097_MD_0000000000011596 crossref_primary_10_3390_cancers14163999 crossref_primary_10_1016_j_biomaterials_2024_122514 crossref_primary_10_2217_bmm_2022_0409 crossref_primary_10_1007_s00345_017_2116_3 crossref_primary_10_1007_s00345_020_03586_1 crossref_primary_10_1007_s12254_018_0422_0 crossref_primary_10_1111_ijun_12181 crossref_primary_10_1002_cam4_71243 crossref_primary_10_2217_fon_2018_0459 crossref_primary_10_1016_j_prp_2018_11_015 crossref_primary_10_1038_s10038_018_0437_8 crossref_primary_10_1245_s10434_025_17617_x crossref_primary_10_3748_wjg_v25_i23_2898 crossref_primary_10_3390_ijms19061622 crossref_primary_10_1002_cpt_1450 crossref_primary_10_1002_jbm_a_36999 crossref_primary_10_3390_molecules29122919 crossref_primary_10_3389_fonc_2022_1001843 crossref_primary_10_1080_13880209_2019_1626449 crossref_primary_10_1111_jcmm_13487 crossref_primary_10_1186_s13578_023_00997_6 crossref_primary_10_1007_s00280_019_03873_8 crossref_primary_10_1177_2632010X241276943 crossref_primary_10_3389_fruro_2024_1309532 crossref_primary_10_1007_s00428_024_03875_9 crossref_primary_10_1158_1078_0432_CCR_20_4796 crossref_primary_10_3892_mmr_2021_12215 crossref_primary_10_3233_BLC_200314 crossref_primary_10_3390_diagnostics12112849 crossref_primary_10_1002_cti2_1248 crossref_primary_10_1016_j_biopha_2020_110059 crossref_primary_10_1093_toxsci_kfaa087 crossref_primary_10_1016_j_heliyon_2024_e32822 crossref_primary_10_1097_CAD_0000000000001399 crossref_primary_10_1016_j_urolonc_2018_03_019 crossref_primary_10_3389_fcell_2022_912008 crossref_primary_10_1016_j_urolonc_2018_03_015 crossref_primary_10_1016_j_colsurfb_2020_111106 crossref_primary_10_1016_j_pdpdt_2019_05_036 crossref_primary_10_1016_j_prp_2022_154037 crossref_primary_10_1038_nrdp_2017_22 crossref_primary_10_1097_JOM_0000000000002907 crossref_primary_10_1371_journal_pone_0188827 crossref_primary_10_3389_fgene_2020_00607 crossref_primary_10_1016_j_gene_2020_144924 crossref_primary_10_1016_j_annonc_2020_02_009 crossref_primary_10_3390_jcm11041038 crossref_primary_10_1186_s12894_019_0461_9 crossref_primary_10_3390_nu14071367 crossref_primary_10_1111_cas_13963 crossref_primary_10_1002_adtp_202000032 crossref_primary_10_1002_cncr_31817 crossref_primary_10_1007_s11626_019_00363_2 crossref_primary_10_1016_j_urolonc_2020_01_008 crossref_primary_10_1186_s12957_020_01943_3 crossref_primary_10_1007_s11626_017_0217_3 crossref_primary_10_1002_cac2_12408 crossref_primary_10_1016_j_molmed_2024_04_004 crossref_primary_10_1080_07853890_2021_1950920 crossref_primary_10_1002_2211_5463_13262 crossref_primary_10_1038_s41467_023_38160_x crossref_primary_10_1016_j_ejso_2019_07_021 crossref_primary_10_3389_fimmu_2024_1419126 crossref_primary_10_1259_bjr_20190401 crossref_primary_10_3390_cancers16223784 crossref_primary_10_1038_s41585_018_0055_4 crossref_primary_10_3233_BLC_200306 crossref_primary_10_1038_s41598_018_33397_9 crossref_primary_10_1186_s12935_021_02119_z crossref_primary_10_1155_2022_8408328 crossref_primary_10_4103_UA_UA_186_20 crossref_primary_10_1038_s41585_021_00448_2 crossref_primary_10_1186_s12885_023_11182_w crossref_primary_10_3389_fsurg_2021_753547 crossref_primary_10_1080_14737140_2020_1807334 crossref_primary_10_1155_2021_7733654 crossref_primary_10_3390_diagnostics15060716 crossref_primary_10_1111_cpr_12614 crossref_primary_10_3892_ol_2020_11839 crossref_primary_10_1186_s12935_021_01954_4 crossref_primary_10_3892_mmr_2018_8711 crossref_primary_10_1038_s41467_020_18916_5 crossref_primary_10_1158_1078_0432_CCR_17_1510 crossref_primary_10_22465_juo_255000300015 crossref_primary_10_3390_nu14061132 crossref_primary_10_1016_j_jddst_2023_104873 crossref_primary_10_3389_fgene_2021_652995 crossref_primary_10_3390_genes13030422 crossref_primary_10_1186_s12885_024_12490_5 crossref_primary_10_1007_s12253_019_00689_y crossref_primary_10_3390_jcm9072191 crossref_primary_10_1016_j_euo_2019_04_009 crossref_primary_10_1007_s00432_022_04449_5 crossref_primary_10_3390_cancers14030487 crossref_primary_10_3389_fgene_2022_1035484 crossref_primary_10_7759_cureus_9957 crossref_primary_10_1002_jcb_28278 crossref_primary_10_1186_s12885_022_09376_9 crossref_primary_10_3389_fgene_2022_892535 crossref_primary_10_1186_s13046_018_0921_1 crossref_primary_10_1371_journal_pone_0186214 crossref_primary_10_1002_cam4_2768 crossref_primary_10_1016_j_clgc_2017_07_001 crossref_primary_10_31083_j_fbl2810242 crossref_primary_10_2217_fon_2021_1151 crossref_primary_10_1080_20905998_2025_2553479 crossref_primary_10_3389_fimmu_2024_1512203 crossref_primary_10_1186_s12885_017_3746_y crossref_primary_10_1016_j_cdtm_2019_08_003 crossref_primary_10_1016_j_euros_2024_08_001 crossref_primary_10_1158_0008_5472_CAN_21_1518 crossref_primary_10_1186_s12885_021_09006_w crossref_primary_10_1245_s10434_025_17234_8 crossref_primary_10_1007_s00394_019_01907_8 crossref_primary_10_1007_s11356_023_27132_9 crossref_primary_10_3390_jcm10163683 crossref_primary_10_1159_000509957 crossref_primary_10_1186_s12935_020_1108_3 crossref_primary_10_1038_s41419_024_07245_w crossref_primary_10_3390_ijerph19052714 crossref_primary_10_1038_s41467_020_18640_0 crossref_primary_10_3390_ijms23105453 crossref_primary_10_1002_jbio_202200009 crossref_primary_10_1186_s12943_023_01856_1 crossref_primary_10_2147_CMAR_S295675 crossref_primary_10_1080_14796694_2024_2342227 crossref_primary_10_1289_EHP9895 crossref_primary_10_1186_s12880_024_01318_0 crossref_primary_10_1016_j_euf_2023_08_004 crossref_primary_10_1007_s12094_023_03270_x crossref_primary_10_1186_s12943_020_1143_7 crossref_primary_10_3390_cancers14215346 crossref_primary_10_3390_cancers14102545 crossref_primary_10_1016_j_annepidem_2023_06_002 crossref_primary_10_3390_cells10010159 crossref_primary_10_1016_j_canlet_2019_06_018 crossref_primary_10_1038_s41571_023_00744_3 crossref_primary_10_3390_jcm12093092 crossref_primary_10_1186_s12957_023_03103_9 crossref_primary_10_1136_bmjopen_2021_050728 crossref_primary_10_1016_j_euf_2021_01_006 crossref_primary_10_1016_j_mpsur_2019_07_003 crossref_primary_10_3389_fonc_2025_1519103 crossref_primary_10_1016_j_urolonc_2018_05_014 crossref_primary_10_1186_s13690_025_01585_5 crossref_primary_10_2147_CMAR_S259117 crossref_primary_10_1007_s00432_024_05798_z crossref_primary_10_3390_ijms24032609 crossref_primary_10_1136_bmjopen_2019_030850 crossref_primary_10_1016_j_euo_2018_09_012 crossref_primary_10_1016_j_canlet_2025_217438 crossref_primary_10_1093_ajcn_nqaa215 crossref_primary_10_1016_j_canlet_2020_06_018 crossref_primary_10_1136_bmjopen_2023_076663 crossref_primary_10_25100_cm_v50i4_4212 crossref_primary_10_3389_fnut_2023_992608 crossref_primary_10_1016_j_heliyon_2024_e35475 crossref_primary_10_1186_s13046_019_1262_4 crossref_primary_10_3390_cancers14061576 crossref_primary_10_3390_cancers13102327 crossref_primary_10_3389_fimmu_2024_1427124 crossref_primary_10_1186_s13045_019_0780_z crossref_primary_10_1016_j_canep_2019_101584 crossref_primary_10_1186_s13062_025_00597_z crossref_primary_10_1038_s41598_025_96089_1 crossref_primary_10_1097_MOU_0000000000000542 crossref_primary_10_3389_fonc_2019_00488 crossref_primary_10_3389_fonc_2021_696422 crossref_primary_10_1002_jcla_23351 crossref_primary_10_2147_CMAR_S223172 crossref_primary_10_3389_fphar_2025_1609354 crossref_primary_10_1007_s11255_022_03260_y crossref_primary_10_1016_j_eururo_2019_09_035 crossref_primary_10_1002_jum_15659 crossref_primary_10_1016_j_soncn_2021_151226 crossref_primary_10_1007_s12038_019_9903_5 crossref_primary_10_1016_j_eururo_2016_10_008 crossref_primary_10_1016_j_biopha_2019_109490 crossref_primary_10_1016_j_clinbiochem_2020_12_006 crossref_primary_10_3390_ijerph20032202 crossref_primary_10_1002_bco2_50 crossref_primary_10_1038_s41388_021_01672_1 crossref_primary_10_3389_fonc_2022_928204 crossref_primary_10_1038_s41598_025_85133_9 crossref_primary_10_1097_MD_0000000000033719 crossref_primary_10_1016_j_mcp_2024_101989 crossref_primary_10_1080_20905998_2025_2501888 crossref_primary_10_2147_IJN_S522421 crossref_primary_10_1007_s12094_017_1710_6 crossref_primary_10_3390_biology11020259 crossref_primary_10_3390_diagnostics11101928 crossref_primary_10_1039_C8RA06548A crossref_primary_10_1177_03915603211007018 crossref_primary_10_3390_cells9051213 crossref_primary_10_1016_j_critrevonc_2019_01_008 crossref_primary_10_1038_s41388_019_0964_6 crossref_primary_10_1016_S1470_2045_18_30693_4 crossref_primary_10_3389_fonc_2021_650678 crossref_primary_10_1186_s12885_017_3302_9 crossref_primary_10_1186_s12894_020_00610_9 crossref_primary_10_3389_fgene_2022_837301 crossref_primary_10_1007_s40495_017_0116_z crossref_primary_10_2217_fon_2017_0346 crossref_primary_10_1007_s00345_018_2354_z crossref_primary_10_1007_s44178_024_00076_x crossref_primary_10_1016_j_urolonc_2022_04_010 crossref_primary_10_15252_emmm_201708163 crossref_primary_10_1007_s00428_018_2310_8 crossref_primary_10_1016_j_ajpath_2018_11_018 crossref_primary_10_1111_ecc_13392 crossref_primary_10_1016_j_cellimm_2018_01_018 crossref_primary_10_3389_fmolb_2021_780329 crossref_primary_10_3389_fonc_2022_895460 crossref_primary_10_1016_j_ebiom_2019_08_074 crossref_primary_10_3892_ol_2021_13078 crossref_primary_10_1016_j_omtn_2022_10_001 crossref_primary_10_1007_s13659_023_00400_4 crossref_primary_10_3389_fphar_2025_1629709 crossref_primary_10_1155_2021_5510318 crossref_primary_10_1016_j_jprot_2018_10_008 crossref_primary_10_1038_s41598_018_19199_z crossref_primary_10_1080_0284186X_2023_2199461 crossref_primary_10_1186_s13287_020_01973_4 crossref_primary_10_1016_j_clgc_2019_01_007 crossref_primary_10_1080_15384101_2018_1557490 crossref_primary_10_1111_ans_15134 crossref_primary_10_1016_j_urolonc_2021_06_001 crossref_primary_10_3389_fcell_2021_783050 crossref_primary_10_1007_s10555_023_10152_9 crossref_primary_10_3390_cancers16081536 crossref_primary_10_1007_s00330_020_07153_5 crossref_primary_10_1016_j_omtn_2021_08_032 crossref_primary_10_1186_s12935_021_01948_2 crossref_primary_10_1002_2211_5463_13616 crossref_primary_10_1016_j_mpsur_2025_07_020 crossref_primary_10_1038_s41417_019_0085_y crossref_primary_10_1097_MS9_0000000000000413 crossref_primary_10_1155_2022_9304552 crossref_primary_10_1038_s41565_023_01577_y crossref_primary_10_1177_03946320231166774 crossref_primary_10_1002_jbio_201960025 crossref_primary_10_1016_j_ebiom_2025_105801 crossref_primary_10_3389_fonc_2021_633462 crossref_primary_10_4103_ijnm_ijnm_51_21 crossref_primary_10_1016_j_prp_2019_04_021 crossref_primary_10_1186_s12957_018_1507_2 crossref_primary_10_1155_2018_3453808 crossref_primary_10_1186_s12943_018_0877_y crossref_primary_10_1002_jcp_28038 crossref_primary_10_3390_cancers10040100 crossref_primary_10_1155_2020_8283401 crossref_primary_10_1186_s12894_023_01346_y crossref_primary_10_1093_mutage_geaf007 crossref_primary_10_1186_s12885_020_07655_x crossref_primary_10_1007_s10528_020_09962_1 crossref_primary_10_1016_j_acthis_2021_151745 crossref_primary_10_1080_03014460_2019_1707873 crossref_primary_10_1186_s12935_020_01392_8 crossref_primary_10_1016_j_urolonc_2021_06_021 crossref_primary_10_7759_cureus_63480 crossref_primary_10_1007_s00204_021_03173_2 crossref_primary_10_1002_cnr2_1406 crossref_primary_10_1038_s41598_022_10029_x crossref_primary_10_1155_2018_5682078 crossref_primary_10_4103_INJMS_INJMS_108_19 crossref_primary_10_3389_fcimb_2024_1374944 crossref_primary_10_1155_2022_1146186 crossref_primary_10_1186_s12894_022_01084_7 crossref_primary_10_1002_adma_202304249 crossref_primary_10_1016_S1470_2045_22_00704_5 crossref_primary_10_1186_s12859_021_04235_z crossref_primary_10_1016_j_eururo_2020_09_006 crossref_primary_10_3389_fonc_2019_01402 crossref_primary_10_1080_15384101_2020_1852746 crossref_primary_10_1038_s41419_023_05598_2 crossref_primary_10_3389_fvets_2022_986269 crossref_primary_10_1177_0391560321993588 crossref_primary_10_1007_s00292_019_0606_3 crossref_primary_10_1002_bco2_147 crossref_primary_10_1002_kjm2_12457 crossref_primary_10_2147_OTT_S257056 crossref_primary_10_3389_fmed_2022_949567 crossref_primary_10_3389_fphar_2020_549338 crossref_primary_10_1016_j_jconrel_2022_09_055 crossref_primary_10_1111_iju_14933 crossref_primary_10_1186_s12967_024_05420_3 crossref_primary_10_1158_0008_5472_CAN_19_2254 crossref_primary_10_1016_j_acuroe_2023_06_006 crossref_primary_10_1155_2022_7931393 crossref_primary_10_3390_diagnostics13101745 crossref_primary_10_3389_fonc_2021_704946 crossref_primary_10_1007_s10654_019_00597_0 crossref_primary_10_1007_s13402_021_00608_x crossref_primary_10_1186_s12882_022_02796_6 crossref_primary_10_1002_cam4_70672 crossref_primary_10_3390_cancers12051304 crossref_primary_10_1155_2021_7608178 crossref_primary_10_1007_s00259_022_06027_w crossref_primary_10_1002_pol_20241113 crossref_primary_10_4103_UROS_UROS_5_19 crossref_primary_10_1016_j_ctro_2021_08_001 crossref_primary_10_1186_s12985_017_0818_1 crossref_primary_10_3390_ijms20061291 crossref_primary_10_1080_14737140_2023_2288140 crossref_primary_10_1002_cam4_3060 crossref_primary_10_1177_1533033820933969 crossref_primary_10_1177_15330338211039110 crossref_primary_10_1080_01635581_2022_2143536 crossref_primary_10_1007_s10552_020_01294_0 crossref_primary_10_3389_fonc_2025_1546160 crossref_primary_10_1080_21655979_2021_1962485 crossref_primary_10_1111_bju_14368 crossref_primary_10_4274_jus_galenos_2022_2022_0037 crossref_primary_10_3389_fpsyg_2024_1252832 crossref_primary_10_3389_fonc_2025_1564826 crossref_primary_10_1002_tox_23328 crossref_primary_10_1111_ajco_14191 crossref_primary_10_1002_kjm2_12091 crossref_primary_10_1186_s12885_022_10103_7 crossref_primary_10_1016_j_gene_2019_144077 crossref_primary_10_1038_nrurol_2017_11 crossref_primary_10_1016_j_asjsur_2022_12_055 crossref_primary_10_3389_fonc_2020_01332 crossref_primary_10_1016_j_acuroe_2021_03_002 crossref_primary_10_1016_j_jasc_2021_02_002 crossref_primary_10_3389_fonc_2023_1228185 crossref_primary_10_1007_s00345_018_2438_9 crossref_primary_10_1016_j_cellsig_2020_109886 crossref_primary_10_1002_tox_23331 crossref_primary_10_1016_j_lfs_2023_122253 crossref_primary_10_1007_s00345_022_04017_z crossref_primary_10_1111_cas_14502 crossref_primary_10_1016_j_lfs_2020_118154 crossref_primary_10_1002_cam4_3006 crossref_primary_10_1038_s41419_017_0112_6 crossref_primary_10_3390_cancers12061507 crossref_primary_10_3892_mmr_2018_8402 crossref_primary_10_3389_fcell_2020_606123 crossref_primary_10_3389_fimmu_2017_01147 crossref_primary_10_1155_2020_8143158 crossref_primary_10_1002_jrs_5783 crossref_primary_10_2217_imt_2021_0042 crossref_primary_10_1016_j_omto_2019_12_014 crossref_primary_10_3389_fmed_2023_1193133 crossref_primary_10_1111_bju_15239 crossref_primary_10_3389_fgene_2022_912171 crossref_primary_10_1016_j_cancergen_2025_07_007 crossref_primary_10_3390_jcm12020728 crossref_primary_10_1007_s00345_022_03954_z crossref_primary_10_3892_ol_2018_9142 crossref_primary_10_1016_j_cyto_2020_155355 crossref_primary_10_1007_s11934_018_0859_z crossref_primary_10_1002_jgm_3527 crossref_primary_10_1097_PAS_0000000000001264 crossref_primary_10_1038_s41388_020_01486_7 crossref_primary_10_1038_s41467_023_41139_3 crossref_primary_10_1111_iju_15370 crossref_primary_10_1007_s11864_019_0609_6 crossref_primary_10_1016_j_euo_2019_06_014 crossref_primary_10_1186_s12935_021_02114_4 crossref_primary_10_3390_nu10111756 crossref_primary_10_1002_mc_22715 crossref_primary_10_1016_j_pop_2019_02_009 crossref_primary_10_1007_s11255_021_03073_5 crossref_primary_10_1016_j_isjp_2020_02_002 crossref_primary_10_1002_cbin_11292 crossref_primary_10_1016_j_heliyon_2022_e12102 crossref_primary_10_3322_caac_21660 crossref_primary_10_3390_cancers13235989 crossref_primary_10_1080_21681805_2019_1708967 crossref_primary_10_7759_cureus_27330 crossref_primary_10_1007_s11255_024_03965_2 crossref_primary_10_1016_j_urolonc_2019_10_016 crossref_primary_10_1016_j_urolonc_2019_04_024 crossref_primary_10_1038_s41419_020_03190_6 crossref_primary_10_3389_fphar_2021_707271 crossref_primary_10_3390_diagnostics12030586 crossref_primary_10_1016_j_acuro_2023_05_004 crossref_primary_10_3389_fonc_2020_01774 crossref_primary_10_1002_slct_202200424 crossref_primary_10_1002_iub_2254 crossref_primary_10_1002_em_22520 crossref_primary_10_7759_cureus_85626 crossref_primary_10_1016_j_carj_2018_07_001 crossref_primary_10_1038_s41585_020_00404_6 crossref_primary_10_1038_s41598_025_92033_5 crossref_primary_10_1016_j_heliyon_2024_e33200 crossref_primary_10_3389_fphar_2020_00164 crossref_primary_10_1055_a_2552_1170 crossref_primary_10_1002_dc_25269 crossref_primary_10_1097_MD_0000000000034130 crossref_primary_10_3390_app11041785 crossref_primary_10_1007_s12253_018_0477_6 crossref_primary_10_1186_s12935_021_01841_y crossref_primary_10_3390_diagnostics11020351 crossref_primary_10_1016_j_pdpdt_2024_104459 crossref_primary_10_1186_s12957_018_1547_7 crossref_primary_10_1016_j_fct_2019_04_012 crossref_primary_10_1007_s11912_021_01091_1 crossref_primary_10_17650_1726_9776_2025_21_1_71_83 crossref_primary_10_1111_iju_14082 crossref_primary_10_1016_j_molmed_2019_10_003 crossref_primary_10_1080_01635581_2019_1609531 crossref_primary_10_1080_14737140_2018_1421461 crossref_primary_10_1186_s12885_018_5137_4 crossref_primary_10_3390_ijms21093360 crossref_primary_10_1007_s00280_018_3518_7 crossref_primary_10_3390_medicina59081452 crossref_primary_10_1186_s12893_024_02553_6 crossref_primary_10_1159_000506291 crossref_primary_10_3389_fimmu_2022_916800 crossref_primary_10_1186_s12967_023_03972_4 crossref_primary_10_1097_JS9_0000000000001065 crossref_primary_10_1016_j_urolonc_2017_01_012 crossref_primary_10_1177_0825859720924936 crossref_primary_10_3390_cancers12102882 crossref_primary_10_1002_cam4_3513 crossref_primary_10_3390_mi12070764 crossref_primary_10_1080_10942912_2023_2252619 crossref_primary_10_15252_embr_201948467 crossref_primary_10_1016_j_kjms_2017_01_004 crossref_primary_10_1002_jcla_23049 crossref_primary_10_1186_s12916_021_01931_8 crossref_primary_10_3389_fgene_2022_992599 crossref_primary_10_2147_CMAR_S323844 crossref_primary_10_1016_j_tice_2022_101762 crossref_primary_10_1111_jcmm_15122 crossref_primary_10_1016_j_currproblcancer_2019_03_002 crossref_primary_10_3389_pore_2023_1611117 crossref_primary_10_1038_s41417_020_00211_6 crossref_primary_10_1016_j_ijrobp_2020_01_015 crossref_primary_10_3390_ijms21176034 crossref_primary_10_1016_j_urology_2020_05_067 crossref_primary_10_1016_j_prp_2023_154887 crossref_primary_10_3892_ijo_2020_4984 crossref_primary_10_1016_j_urolonc_2018_11_001 crossref_primary_10_1097_MOU_0000000000000804 crossref_primary_10_1093_toxres_tfad111 crossref_primary_10_1016_j_eururo_2016_06_040 crossref_primary_10_1002_cam4_1354 crossref_primary_10_1016_j_bioorg_2021_105165 crossref_primary_10_1007_s11010_018_3278_z crossref_primary_10_1016_j_biomaterials_2021_121331 crossref_primary_10_1016_j_euf_2016_07_005 crossref_primary_10_5662_wjm_v14_i2_91889 crossref_primary_10_1007_s10147_020_01690_1 crossref_primary_10_1186_s13046_023_02932_6 crossref_primary_10_3389_fonc_2020_532924 crossref_primary_10_1177_1533033820946787 crossref_primary_10_1289_EHP4495 crossref_primary_10_1097_CEJ_0000000000000404 crossref_primary_10_1007_s12032_025_02900_4 crossref_primary_10_1016_j_envpol_2020_115328 crossref_primary_10_1016_j_ymeth_2022_08_010 crossref_primary_10_3892_ol_2019_10924 crossref_primary_10_4274_uob_galenos_2022_2022_5_1 crossref_primary_10_1158_0008_5472_CAN_16_2621 crossref_primary_10_1111_bju_14791 crossref_primary_10_1097_MD_0000000000016223 crossref_primary_10_1002_jbio_202100354 crossref_primary_10_1186_s12935_020_01660_7 crossref_primary_10_1111_iju_14559 crossref_primary_10_1016_j_euo_2018_04_010 crossref_primary_10_3389_fonc_2022_788568 crossref_primary_10_1111_bju_14720 crossref_primary_10_3390_cancers15061886 crossref_primary_10_1111_vco_12970 crossref_primary_10_1016_j_jsbmb_2024_106623 crossref_primary_10_1016_j_csbj_2024_07_009 crossref_primary_10_1002_dvdy_24487 crossref_primary_10_1038_s41598_022_21747_7 crossref_primary_10_3389_fonc_2021_659166 crossref_primary_10_1016_j_urolonc_2020_07_013 crossref_primary_10_1097_MD_0000000000037590 crossref_primary_10_1016_j_eururo_2018_09_001 crossref_primary_10_1186_s12885_020_07748_7 crossref_primary_10_1371_journal_pone_0264527 crossref_primary_10_3389_fonc_2022_1044830 crossref_primary_10_1016_j_procs_2021_12_058 crossref_primary_10_2147_CMAR_S289986 crossref_primary_10_1007_s00418_021_01965_2 crossref_primary_10_1186_s12894_018_0413_9 crossref_primary_10_3168_jds_2023_24186 crossref_primary_10_1002_cam4_3960 crossref_primary_10_1016_S1470_2045_24_00274_2 crossref_primary_10_1039_C9RA02362C crossref_primary_10_1002_cam4_71059 crossref_primary_10_1016_j_jcpo_2022_100326 crossref_primary_10_1016_j_jhazmat_2024_133760 crossref_primary_10_3389_fonc_2021_782981 crossref_primary_10_3390_ijms21176072 crossref_primary_10_1007_s10735_020_09907_3 crossref_primary_10_1186_s12301_023_00375_1 crossref_primary_10_1186_s12885_019_6503_6 crossref_primary_10_1007_s00394_020_02313_1 crossref_primary_10_1007_s00345_018_2384_6 crossref_primary_10_1007_s00335_021_09896_y crossref_primary_10_2147_CMAR_S371974 crossref_primary_10_3389_fonc_2024_1337997 crossref_primary_10_3390_uro5020011 crossref_primary_10_4103_njcp_njcp_520_22 crossref_primary_10_1016_j_bcp_2023_115870 crossref_primary_10_1038_s41598_022_14097_x crossref_primary_10_1002_cam4_7091 crossref_primary_10_1007_s10238_019_00576_5 crossref_primary_10_1177_03915603211035191 crossref_primary_10_3389_fphar_2021_618668 crossref_primary_10_1007_s11547_018_0918_z crossref_primary_10_1016_j_cclet_2020_03_043 crossref_primary_10_1177_0300060521992900 crossref_primary_10_1016_j_canep_2019_101663 crossref_primary_10_3892_ol_2019_10968 crossref_primary_10_1002_cam4_3981 crossref_primary_10_1080_01635581_2018_1512636 crossref_primary_10_1186_s12894_024_01466_z crossref_primary_10_1111_1754_9485_13317 crossref_primary_10_1177_17562872221079473 crossref_primary_10_1002_mc_23207 crossref_primary_10_3389_fimmu_2022_898493 crossref_primary_10_3390_diagnostics13081393 crossref_primary_10_1158_2326_6066_CIR_18_0758 crossref_primary_10_1080_15384101_2022_2164454 crossref_primary_10_1097_MD_0000000000011830 crossref_primary_10_1177_0300060519864806 crossref_primary_10_3892_ijmm_2019_4385 crossref_primary_10_3233_BLC_200275 crossref_primary_10_1007_s10552_019_1131_7 crossref_primary_10_1007_s10147_017_1187_x crossref_primary_10_3390_biomedicines11010069 crossref_primary_10_2217_pgs_2023_0027 crossref_primary_10_1016_j_ijbiomac_2022_09_047 crossref_primary_10_1007_s43188_020_00075_w crossref_primary_10_1038_s41598_020_60791_z crossref_primary_10_1080_14712598_2017_1366445 crossref_primary_10_1002_ijc_33173 crossref_primary_10_1007_s12253_019_00657_6 crossref_primary_10_1155_2022_8100325 crossref_primary_10_3390_app8122371 crossref_primary_10_3389_fonc_2021_651657 crossref_primary_10_1177_17562872251315930 crossref_primary_10_1097_CAD_0000000000001453 crossref_primary_10_1155_2019_4824902 crossref_primary_10_3892_or_2021_8115 crossref_primary_10_1080_07357907_2020_1839760 crossref_primary_10_2217_bmm_2021_0754 crossref_primary_10_1111_ijun_12308 crossref_primary_10_1098_rsob_220355 crossref_primary_10_1016_j_cellsig_2021_110216 crossref_primary_10_3389_fonc_2022_759153 crossref_primary_10_1002_nau_24050 crossref_primary_10_1002_jcp_28574 crossref_primary_10_3389_fonc_2023_1160965 crossref_primary_10_1002_1878_0261_12035 crossref_primary_10_1002_ctm2_70240 crossref_primary_10_1016_j_clgc_2019_03_009 crossref_primary_10_2147_IJGM_S368573 crossref_primary_10_1038_s41388_022_02371_1 crossref_primary_10_1038_s41419_017_0206_1 crossref_primary_10_1097_MD_0000000000018000 crossref_primary_10_1093_ajhp_zxz027 crossref_primary_10_1186_s12967_020_02475_w crossref_primary_10_3389_fonc_2023_1098523 crossref_primary_10_1016_j_urolonc_2022_10_030 crossref_primary_10_3390_diagnostics13193067 crossref_primary_10_2147_CMAR_S334521 crossref_primary_10_1007_s13402_020_00563_z crossref_primary_10_3389_fgene_2020_00933 crossref_primary_10_1016_j_yrtph_2019_104539 crossref_primary_10_3390_life14070857 crossref_primary_10_1016_j_jad_2023_08_045 crossref_primary_10_3389_fonc_2019_00158 crossref_primary_10_3892_ijmm_2019_4340 crossref_primary_10_3390_cancers15102836 crossref_primary_10_3389_fonc_2022_866013 crossref_primary_10_1038_s41394_019_0177_9 crossref_primary_10_2147_CMAR_S259269 crossref_primary_10_1016_j_bcp_2025_116903 crossref_primary_10_1016_j_euf_2018_08_010 crossref_primary_10_3390_ijms22115565 crossref_primary_10_3390_medicina58101490 crossref_primary_10_3389_fonc_2021_660551 crossref_primary_10_3390_ijms25063473 crossref_primary_10_3390_cancers9040028 crossref_primary_10_1007_s00345_017_2141_2 crossref_primary_10_15252_embr_201643581 crossref_primary_10_1089_dna_2019_5224 crossref_primary_10_1016_j_urolonc_2020_09_015 crossref_primary_10_3389_fonc_2022_774307 crossref_primary_10_1038_s41598_023_50740_x crossref_primary_10_1111_iju_14537 crossref_primary_10_1136_bmjopen_2018_028173 crossref_primary_10_1002_agt2_676 crossref_primary_10_1016_j_urology_2019_04_006 crossref_primary_10_3389_fonc_2022_859707 crossref_primary_10_1016_j_rvsc_2022_12_001 crossref_primary_10_1038_s41419_020_2226_5 crossref_primary_10_1093_carcin_bgz187 crossref_primary_10_3389_fcell_2022_757137 crossref_primary_10_3389_fonc_2023_1170700 crossref_primary_10_1080_01635581_2020_1834591 crossref_primary_10_3389_fimmu_2022_1097730 crossref_primary_10_3390_ijms22063056 crossref_primary_10_1016_j_urolonc_2020_09_004 crossref_primary_10_1080_01635581_2022_2159043 crossref_primary_10_1080_21655979_2022_2037323 crossref_primary_10_1159_000477337 crossref_primary_10_1007_s00120_022_01914_4 crossref_primary_10_3389_fcell_2021_718991 crossref_primary_10_1016_j_xphs_2019_05_006 crossref_primary_10_1016_j_heliyon_2023_e17690 crossref_primary_10_3390_jcm9020605 crossref_primary_10_3389_fonc_2019_01493 crossref_primary_10_1097_MS9_0000000000002581 crossref_primary_10_1186_s12943_018_0771_7 crossref_primary_10_2147_CLEP_S387289 crossref_primary_10_3390_cancers12051253 crossref_primary_10_1007_s11255_023_03667_1 crossref_primary_10_1002_1878_0261_13313 crossref_primary_10_1016_j_ygeno_2020_09_012 crossref_primary_10_1016_j_urolonc_2021_02_009
Cites_doi	10.1002/sim.3733 10.1111/bcp.12306 10.1002/cncr.28397 10.1001/jama.2013.284692 10.1016/j.eururo.2012.09.057 10.1002/ijc.21731 10.1002/ijc.29670 10.1158/1055-9965.EPI-12-1190 10.1016/j.eururo.2012.12.062 10.1289/ehp.1307055 10.2471/BLT.15.164384 10.1016/j.eururo.2013.06.003 10.1007/s00125-014-3456-9 10.1038/bjc.2012.112 10.1080/03008880802285032 10.1016/j.urolonc.2011.08.011 10.1186/s13071-014-0570-y 10.1016/j.eururo.2012.08.009 10.1002/ijc.29210 10.1016/j.eururo.2015.10.024 10.1016/j.urology.2011.08.072 10.1007/s10552-007-9104-7 10.1001/jama.2011.1142 10.1016/S1470-2045(13)70329-2 10.1093/jnci/djr483 10.1016/j.annepidem.2014.11.009 10.1093/jnci/djm004 10.1001/jama.2015.7996 10.1200/JCO.2011.41.0183 10.1016/j.ejca.2015.07.028 10.1016/S1473-3099(06)70521-7 10.1186/1471-2407-14-406 10.1016/j.eururo.2012.07.033 10.1158/1055-9965.EPI-13-0119-T 10.1016/j.eururo.2015.06.042 10.1097/00008469-200508000-00002 10.1111/j.1464-410X.2007.07308.x 10.1016/j.ejca.2007.12.015 10.1016/S1470-2045(08)70175-X
ContentType	Journal Article
Copyright	2016 European Association of Urology European Association of Urology Copyright © 2016 European Association of Urology. Published by Elsevier B.V. All rights reserved.
Copyright_xml	– notice: 2016 European Association of Urology – notice: European Association of Urology – notice: Copyright © 2016 European Association of Urology. Published by Elsevier B.V. All rights reserved.
DBID	AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8
DOI	10.1016/j.eururo.2016.06.010
DatabaseName	CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic
DatabaseTitle	CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic
DatabaseTitleList	MEDLINE - Academic MEDLINE
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Medicine Statistics
EISSN	1873-7560
EndPage	108
ExternalDocumentID	27370177 10_1016_j_eururo_2016_06_010 S0302283816302809 1_s2_0_S0302283816302809
Genre	Journal Article Review
GrantInformation_xml	– fundername: World Health Organization grantid: 001
GroupedDBID	--- --K --M .1- .55 .FO .GJ .~1 0R~ 0~B 1B1 1P~ 1~. 1~5 29G 30W 34G 39C 4.4 457 4G. 53G 5GY 5RE 5VS 7-5 71M 8P~ 8UI AABNK AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AATTM AAXKI AAXUO AAYIC AAYWO ABBQC ABBTS ABFNM ABJNI ABLJU ABMAC ABMZM ABOCM ABWCG ABWVN ABXDB ACDAQ ACIEU ACLOT ACQXL ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO AEBSH AEIPS AEKER AENEX AEUPX AEVXI AEYAO AFJKZ AFPUW AFRHN AFSIO AFTJW AFXIZ AGHFR AGUBO AGYEJ AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP AXJTR BKOJK BLXMC BNPGV CAG COF CS3 CYUIP DU5 E0A EBS EFJIC EFKBS EFLBG EJD EO8 EO9 EP2 EP3 F5P FB. FDB FEDTE FIRID FNPLU FYGXN G-Q GBLVA HVGLF HZ~ IHE J1W KOM M41 MO0 N9A O-L O1H O9- OAUVE OK. OW. OZT P-8 P-9 P2P PC. Q38 RKO ROL RPZ SCC SDF SDG SEL SES SEW SPCBC SSH SSZ T5K UDS UJ6 UV1 X7M Z5R ZGI ZXP ~G- ~HD AACTN AFCTW AFKWA AJOXV AMFUW RIG AAIAV ABLVK ABYKQ AHPSJ AJBFU AZPMC LCYCR ZA5 9DU AAYXX CITATION AGCQF AGRNS CGR CUY CVF ECM EIF NPM 7X8
ID	FETCH-LOGICAL-c470t-f8680abc6ca88bc6d1719d2103ab9cbd9468ff6deb80c105c35f02efd64371ef3
ISICitedReferencesCount	1973
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000390564400034&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	0302-2838
IngestDate	Sun Sep 28 16:18:05 EDT 2025 Mon Jul 21 06:04:01 EDT 2025 Sat Nov 29 04:11:25 EST 2025 Tue Nov 18 21:47:18 EST 2025 Fri Feb 23 02:16:44 EST 2024 Tue Feb 25 20:12:31 EST 2025 Tue Oct 14 19:30:37 EDT 2025
IsPeerReviewed	true
IsScholarly	true
Issue	1
Keywords	Bladder Statistics Mortality Cancer Incidence
Language	English
License	Copyright © 2016 European Association of Urology. Published by Elsevier B.V. All rights reserved.
LinkModel	OpenURL
MergedId	FETCHMERGED-LOGICAL-c470t-f8680abc6ca88bc6d1719d2103ab9cbd9468ff6deb80c105c35f02efd64371ef3
Notes	ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1
PMID	27370177
PQID	1826714525
PQPubID	23479
PageCount	13
ParticipantIDs	proquest_miscellaneous_1826714525 pubmed_primary_27370177 crossref_primary_10_1016_j_eururo_2016_06_010 crossref_citationtrail_10_1016_j_eururo_2016_06_010 elsevier_sciencedirect_doi_10_1016_j_eururo_2016_06_010 elsevier_clinicalkeyesjournals_1_s2_0_S0302283816302809 elsevier_clinicalkey_doi_10_1016_j_eururo_2016_06_010
PublicationCentury	2000
PublicationDate	2017-01-01
PublicationDateYYYYMMDD	2017-01-01
PublicationDate_xml	– month: 01 year: 2017 text: 2017-01-01 day: 01
PublicationDecade	2010
PublicationPlace	Switzerland
PublicationPlace_xml	– name: Switzerland
PublicationTitle	European urology
PublicationTitleAlternate	Eur Urol
PublicationYear	2017
Publisher	Elsevier B.V
Publisher_xml	– name: Elsevier B.V
References	El-Zanaty F, Way AA. Report Egypt Demographic and Health Survey 2005. Cairo, Egypt: Ministry of Health and Population, National Population Council, El-Zanaty and Associates, and ORC Macro; 2006. Turner, Kwok, Chen-Turner, Maduakor, Singh, Loke (bib0650) 2014; 78 Babjuk, Burger, Zigeuner (bib0675) 2013; 64 Croatian National Cancer Registry. Cancer in Croatia 2012 Web site. Moolgavkar, Stevens (bib0525) 1981; 67 Salem, Mahfouz (bib0555) 2012; 79 Grosse, Loomis, Lauby-Secretan (bib0635) 2013; 14 Czech National Cancer Registry. Cancer incidence 2010 in the Czech Republic Web site. Forman, Bray, Brewster (bib0400) 2013; X Cumberbatch, Rota, Catto, La (bib0505) 2016; 70 Loader C. Smoothing: Local Regression Techniques Web site. Ng, Freeman, Fleming (bib0375) 2014; 311 UK, England, Office for National Statistics Web site. Levin, Bell, Sund (bib0645) 2015; 58 Gakis, Efstathiou, Lerner (bib0680) 2013; 63 Felix, Soliman, Khaled (bib0560) 2008; 19 Segi (bib0485) 1960 National Cancer Registry Ireland Web site. Scottish Cancer Registry Web site. Marcos-Gragera, Mallone, Kiemeney (bib0665) 2015; 51 Janssen, Kunst (bib0695) 2004; 82 International rules for multiple primary cancers (ICD-0 ed. 3). Eur J Cancer Prev 2005; 14:307-8. Rushton, Hutchings, Fortunato (bib0595) 2012; 107 Lewis, Habel, Quesenberry (bib0640) 2015; 314 Dimitrova N, Vukov M, Valerianova Z. Report cancer incidence in Bulgaria 2011. Sofia, Bulgaria: Bulgarian National Cancer Registry; 2013. WHO Mortality Database World Health Organisation Web site. . Leal, Luengo-Fernandez, Sullivan, Witjes (bib0670) 2016; 69 Freedman, Silverman, Hollenbeck, Schatzkin, Abnet (bib0510) 2011; 306 Eriksen, Mackay, Schluger, Islami Gomeshtapeh, Drope (bib0540) 2015 Purdue, Hutchings, Rushton, Silverman (bib0600) 2015; 25 Moscow Research Oncological Institute, Russian Federation Web site. Vlaanderen, Straif, Ruder (bib0590) 2014; 122 Bray, Ferlay, Laversanne (bib0395) 2015; 137 Park, Jee, Shin (bib0515) 2014; 14 Steinmaus, Ferreccio, Romo (bib0610) 2013; 22 Marshall, Ferreccio, Yuan (bib0605) 2007; 99 GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide: IARC CancerBase No. 11. International Agency for Research on Cancer Web site. Gouda, Mokhtar, Bilal, El-Bolkainy, El-Bolkainy (bib0565) 2007; 19 Parkin (bib0380) 2006; 118 Ferlay, Soerjomataram, Dikshit (bib0475) 2015; 136 Nielsen, Smith, Meyer (bib0700) 2014; 120 NORDCAN: Cancer incidence, mortality, prevalence and survival in the Nordic Countries, Version 7.1. Association of the Nordic Cancer Registries. Danish Cancer Society Web site. Clegg, Hankey, Tiwari, Feuer, Edwards (bib0490) 2009; 28 Surveillance, Epidemiology, and End Results Program Research Data (1973-2012), National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch Web site. Centres for Disease Control and Prevention. Trends in current cigarette smoking among high school students and adults, United States, 1965-2011. Centres for Disease Control and Prevention Web site. Parkin, Sitas, Chirenje, Stein, Abratt, Wabinga (bib0550) 2008; 9 Parkin (bib0385) 2008; 218 Regidor, Gutierrez-Fisac, de lS, Fernandez (bib0535) 2010; 21 Steinmann, Keiser, Bos, Tanner, Utzinger (bib0545) 2006; 6 Pesch, Gawrych, Rabstein (bib0620) 2013; 22 Antoni, Soerjomataram, Moller, Bray, Ferlay (bib0720) 2016; 94 New Zealand National Ministry of Health Web site. World Health Organisation. WHO Report on the Global Tobacco Epidemic, Country profile: Malawi Web site. Malmstrom (bib0690) 2008; 101 Larre, Catto, Cookson (bib0655) 2013; 63 Antonova, Toncheva, Grigorov (bib0615) 2015; 20 Jacobs, Montgomery, Zhang, Skolarus, Weizer, Hollenbeck (bib0625) 2012; 30 Cogliano, Baan, Straif (bib0585) 2011; 103 Makaula, Sadalaki, Muula, Kayuni, Jemu, Bloch (bib0580) 2014; 7 Report Caisse nationale de l’assurance maladie. Risque de cancer de la vessie chez les personnes diabétiques traitées par pioglitazone en France: une étude de cohorte sur les données du SNIIRAM et du PMSI,;1; 2011. January 7, 2016; Paris, France. Kamat, Hegarty, Gee (bib0660) 2013; 63 Karim-Kos, de, Soerjomataram, Lemmens, Siesling, Coebergh (bib0685) 2008; 44 Cancer incidence in five continents, CI5plus. IARC CancerBase No. 9. International Agency for Research on Cancer Web site. (bib0715) 2014 R Development Core Team. R: A language and environment for statistical computing [computer programme]. Vienna, Austria: R Foundation for Statistical Computing; 2014. Australian Cancer Database. Australian Institute of Health and Welfare Web site. United Nations Development Programme. Human Development Index (HDI) Web site. Agudo, Bonet, Travier (bib0520) 2012; 30 Republic of Korea National Cancer Centre Web site. Burger, Catto, Dalbagni (bib0370) 2013; 63 Cancer incidence in five continents, Vol. I–X. International Agency for Research on Cancer Web site. European Cancer Observatory: Cancer incidence, mortality, prevalence and survival in Europe. European Network of Cancer Registries, International Agency for Research on Cancer Web site. Moolgavkar (10.1016/j.eururo.2016.06.010_bib0525) 1981; 67 Makaula (10.1016/j.eururo.2016.06.010_bib0580) 2014; 7 Malmstrom (10.1016/j.eururo.2016.06.010_bib0690) 2008; 101 10.1016/j.eururo.2016.06.010_bib0570 Parkin (10.1016/j.eururo.2016.06.010_bib0380) 2006; 118 Parkin (10.1016/j.eururo.2016.06.010_bib0385) 2008; 218 10.1016/j.eururo.2016.06.010_bib0450 Purdue (10.1016/j.eururo.2016.06.010_bib0600) 2015; 25 Lewis (10.1016/j.eururo.2016.06.010_bib0640) 2015; 314 Nielsen (10.1016/j.eururo.2016.06.010_bib0700) 2014; 120 Turner (10.1016/j.eururo.2016.06.010_bib0650) 2014; 78 Ferlay (10.1016/j.eururo.2016.06.010_bib0475) 2015; 136 Karim-Kos (10.1016/j.eururo.2016.06.010_bib0685) 2008; 44 10.1016/j.eururo.2016.06.010_bib0415 Regidor (10.1016/j.eururo.2016.06.010_bib0535) 2010; 21 Marcos-Gragera (10.1016/j.eururo.2016.06.010_bib0665) 2015; 51 Antoni (10.1016/j.eururo.2016.06.010_bib0720) 2016; 94 10.1016/j.eururo.2016.06.010_bib0530 10.1016/j.eururo.2016.06.010_bib0410 10.1016/j.eururo.2016.06.010_bib0575 Janssen (10.1016/j.eururo.2016.06.010_bib0695) 2004; 82 10.1016/j.eururo.2016.06.010_bib0495 10.1016/j.eururo.2016.06.010_bib0455 Forman (10.1016/j.eururo.2016.06.010_bib0400) 2013; X 10.1016/j.eururo.2016.06.010_bib0460 Parkin (10.1016/j.eururo.2016.06.010_bib0550) 2008; 9 Gakis (10.1016/j.eururo.2016.06.010_bib0680) 2013; 63 Agudo (10.1016/j.eururo.2016.06.010_bib0520) 2012; 30 Steinmaus (10.1016/j.eururo.2016.06.010_bib0610) 2013; 22 Bray (10.1016/j.eururo.2016.06.010_bib0395) 2015; 137 Vlaanderen (10.1016/j.eururo.2016.06.010_bib0590) 2014; 122 10.1016/j.eururo.2016.06.010_bib0705 10.1016/j.eururo.2016.06.010_bib0420 10.1016/j.eururo.2016.06.010_bib0465 Cumberbatch (10.1016/j.eururo.2016.06.010_bib0505) 2016; 70 Jacobs (10.1016/j.eururo.2016.06.010_bib0625) 2012; 30 10.1016/j.eururo.2016.06.010_bib0425 Burger (10.1016/j.eururo.2016.06.010_bib0370) 2013; 63 10.1016/j.eururo.2016.06.010_bib0500 Ng (10.1016/j.eururo.2016.06.010_bib0375) 2014; 311 10.1016/j.eururo.2016.06.010_bib0390 Marshall (10.1016/j.eururo.2016.06.010_bib0605) 2007; 99 10.1016/j.eururo.2016.06.010_bib0470 Salem (10.1016/j.eururo.2016.06.010_bib0555) 2012; 79 Levin (10.1016/j.eururo.2016.06.010_bib0645) 2015; 58 Segi (10.1016/j.eururo.2016.06.010_bib0485) 1960 Clegg (10.1016/j.eururo.2016.06.010_bib0490) 2009; 28 (10.1016/j.eururo.2016.06.010_bib0715) 2014 Rushton (10.1016/j.eururo.2016.06.010_bib0595) 2012; 107 Kamat (10.1016/j.eururo.2016.06.010_bib0660) 2013; 63 Leal (10.1016/j.eururo.2016.06.010_bib0670) 2016; 69 Eriksen (10.1016/j.eururo.2016.06.010_bib0540) 2015 10.1016/j.eururo.2016.06.010_bib0630 10.1016/j.eururo.2016.06.010_bib0430 10.1016/j.eururo.2016.06.010_bib0435 10.1016/j.eururo.2016.06.010_bib0710 Freedman (10.1016/j.eururo.2016.06.010_bib0510) 2011; 306 Felix (10.1016/j.eururo.2016.06.010_bib0560) 2008; 19 Gouda (10.1016/j.eururo.2016.06.010_bib0565) 2007; 19 Steinmann (10.1016/j.eururo.2016.06.010_bib0545) 2006; 6 Babjuk (10.1016/j.eururo.2016.06.010_bib0675) 2013; 64 10.1016/j.eururo.2016.06.010_bib0480 Park (10.1016/j.eururo.2016.06.010_bib0515) 2014; 14 Larre (10.1016/j.eururo.2016.06.010_bib0655) 2013; 63 10.1016/j.eururo.2016.06.010_bib0405 Grosse (10.1016/j.eururo.2016.06.010_bib0635) 2013; 14 Pesch (10.1016/j.eururo.2016.06.010_bib0620) 2013; 22 10.1016/j.eururo.2016.06.010_bib0365 Cogliano (10.1016/j.eururo.2016.06.010_bib0585) 2011; 103 10.1016/j.eururo.2016.06.010_bib0440 10.1016/j.eururo.2016.06.010_bib0445 Antonova (10.1016/j.eururo.2016.06.010_bib0615) 2015; 20 27417034 - Eur Urol. 2017 Jan;71(1):109-110. doi: 10.1016/j.eururo.2016.06.040.
References_xml	– reference: Moscow Research Oncological Institute, Russian Federation Web site. – volume: 122 start-page: 661 year: 2014 end-page: 666 ident: bib0590 article-title: Tetrachloroethylene exposure and bladder cancer risk: a meta-analysis of dry-cleaning-worker studies publication-title: Environ Health Perspect – reference: United Nations Development Programme. Human Development Index (HDI) Web site. – reference: R Development Core Team. R: A language and environment for statistical computing [computer programme]. Vienna, Austria: R Foundation for Statistical Computing; 2014. – reference: Report Caisse nationale de l’assurance maladie. Risque de cancer de la vessie chez les personnes diabétiques traitées par pioglitazone en France: une étude de cohorte sur les données du SNIIRAM et du PMSI,;1; 2011. January 7, 2016; Paris, France. – volume: 79 start-page: 379 year: 2012 end-page: 383 ident: bib0555 article-title: Changing patterns (age, incidence, and pathologic types) of schistosoma-associated bladder cancer in Egypt in the past decade publication-title: Urology – volume: 14 start-page: 807 year: 2013 end-page: 808 ident: bib0635 article-title: Carcinogenicity of some drugs and herbal products publication-title: Lancet Oncol – volume: 78 start-page: 258 year: 2014 end-page: 273 ident: bib0650 article-title: Thiazolidinediones and associated risk of bladder cancer: A systematic review and meta-analysis publication-title: Br J Clin Pharmacol – reference: Croatian National Cancer Registry. Cancer in Croatia 2012 Web site. – volume: 58 start-page: 493 year: 2015 end-page: 504 ident: bib0645 article-title: Pioglitazone and bladder cancer risk: a multipopulation pooled, cumulative exposure analysis publication-title: Diabetologia – volume: 103 start-page: 1827 year: 2011 end-page: 1839 ident: bib0585 article-title: Preventable exposures associated with human cancers publication-title: J Natl Cancer Inst – volume: 120 start-page: 86 year: 2014 end-page: 95 ident: bib0700 article-title: Trends in stage-specific incidence rates for urothelial carcinoma of the bladder in the United States: 1988-2006 publication-title: Cancer – volume: 69 start-page: 438 year: 2016 end-page: 447 ident: bib0670 article-title: Economic burden of bladder cancer across the European Union publication-title: Eur Urol – volume: 28 start-page: 3670 year: 2009 end-page: 3682 ident: bib0490 article-title: Estimating average annual per cent change in trend analysis publication-title: Stat Med – volume: 19 start-page: 421 year: 2008 end-page: 429 ident: bib0560 article-title: The changing patterns of bladder cancer in Egypt over the past 26 years publication-title: Cancer Causes Control – volume: 314 start-page: 265 year: 2015 end-page: 277 ident: bib0640 article-title: Pioglitazone use and risk of bladder cancer and other common cancers in persons with diabetes publication-title: JAMA – volume: 137 start-page: 2060 year: 2015 end-page: 2071 ident: bib0395 article-title: Cancer incidence in five continents: Inclusion criteria, highlights from Volume X and the global status of cancer registration publication-title: Int J Cancer – reference: National Cancer Registry Ireland Web site. – reference: El-Zanaty F, Way AA. Report Egypt Demographic and Health Survey 2005. Cairo, Egypt: Ministry of Health and Population, National Population Council, El-Zanaty and Associates, and ORC Macro; 2006. – reference: New Zealand National Ministry of Health Web site. – volume: 22 start-page: 2055 year: 2013 end-page: 2065 ident: bib0620 article-title: N-acetyltransferase 2 phenotype, occupation, and bladder cancer risk: results from the EPIC cohort publication-title: Cancer Epidemiol Biomarkers Prev – reference: Centres for Disease Control and Prevention. Trends in current cigarette smoking among high school students and adults, United States, 1965-2011. Centres for Disease Control and Prevention Web site. – volume: 94 start-page: 174 year: 2016 end-page: 184 ident: bib0720 article-title: An assessment of GLOBOCAN methods for deriving national estimates of cancer incidence publication-title: Bull World Health Organ – volume: 20 start-page: 1397 year: 2015 end-page: 1406 ident: bib0615 article-title: Bladder cancer risk from the perspective of genetic polymorphisms in the carcinogen metabolising enzymes publication-title: J BUON – volume: 63 start-page: 45 year: 2013 end-page: 57 ident: bib0680 article-title: ICUD-EAU International Consultation on Bladder Cancer 2012: Radical cystectomy and bladder preservation for muscle-invasive urothelial carcinoma of the bladder publication-title: Eur Urol – reference: WHO Mortality Database World Health Organisation Web site. – reference: European Cancer Observatory: Cancer incidence, mortality, prevalence and survival in Europe. European Network of Cancer Registries, International Agency for Research on Cancer Web site. – volume: 136 start-page: E359 year: 2015 end-page: E386 ident: bib0475 article-title: Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 publication-title: Int J Cancer – volume: 306 start-page: 737 year: 2011 end-page: 745 ident: bib0510 article-title: Association between smoking and risk of bladder cancer among men and women publication-title: JAMA – volume: 25 start-page: 188 year: 2015 end-page: 192 ident: bib0600 article-title: The proportion of cancer attributable to occupational exposures publication-title: Ann Epidemiol – volume: 99 start-page: 920 year: 2007 end-page: 928 ident: bib0605 article-title: Fifty-year study of lung and bladder cancer mortality in Chile related to arsenic in drinking water publication-title: J Natl Cancer Inst – reference: Surveillance, Epidemiology, and End Results Program Research Data (1973-2012), National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch Web site. – volume: 311 start-page: 183 year: 2014 end-page: 192 ident: bib0375 article-title: Smoking prevalence and cigarette consumption in 187 countries, 1980-2012 publication-title: JAMA – volume: 101 start-page: 267 year: 2008 end-page: 269 ident: bib0690 article-title: Why has the survival of patients with bladder cancer not improved? publication-title: BJU Int – volume: 9 start-page: 683 year: 2008 end-page: 692 ident: bib0550 article-title: Part I: Cancer in indigenous Africans—burden, distribution, and trends publication-title: Lancet Oncol – reference: GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide: IARC CancerBase No. 11. International Agency for Research on Cancer Web site. – volume: 63 start-page: 234 year: 2013 end-page: 241 ident: bib0370 article-title: Epidemiology and risk factors of urothelial bladder cancer publication-title: Eur Urol – reference: Loader C. Smoothing: Local Regression Techniques Web site. – reference: Republic of Korea National Cancer Centre Web site. – volume: 21 year: 2010 ident: bib0535 article-title: Trends in principal cancer risk factors in Spain publication-title: Ann Oncol – reference: Czech National Cancer Registry. Cancer incidence 2010 in the Czech Republic Web site. – reference: NORDCAN: Cancer incidence, mortality, prevalence and survival in the Nordic Countries, Version 7.1. Association of the Nordic Cancer Registries. Danish Cancer Society Web site. – volume: X year: 2013 ident: bib0400 publication-title: Cancer incidence in five continents – volume: 51 start-page: 2217 year: 2015 end-page: 2230 ident: bib0665 article-title: Urinary tract cancer survival in Europe 1999–2007: Results of the population-based study EUROCARE-5 publication-title: Eur J Cancer – reference: Scottish Cancer Registry Web site. – volume: 63 start-page: 1049 year: 2013 end-page: 1058 ident: bib0655 article-title: Screening for bladder cancer: rationale, limitations, whom to target, and perspectives publication-title: Eur Urol – volume: 6 start-page: 411 year: 2006 end-page: 425 ident: bib0545 article-title: Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk publication-title: Lancet Infect Dis – volume: 14 start-page: 406 year: 2014 ident: bib0515 article-title: Attributable fraction of tobacco smoking on cancer using population-based nationwide cancer incidence and mortality data in Korea publication-title: BMC Cancer – volume: 30 start-page: 4550 year: 2012 end-page: 4557 ident: bib0520 article-title: Impact of cigarette smoking on cancer risk in the European prospective investigation into cancer and nutrition study publication-title: J Clin Oncol – year: 2014 ident: bib0715 article-title: Global Status Report on Noncommunicable Diseases – reference: International rules for multiple primary cancers (ICD-0 ed. 3). Eur J Cancer Prev 2005; 14:307-8. – reference: Australian Cancer Database. Australian Institute of Health and Welfare Web site. – volume: 7 start-page: 570 year: 2014 ident: bib0580 article-title: Schistosomiasis in Malawi: A systematic review publication-title: Parasit Vectors – volume: 44 start-page: 1345 year: 2008 end-page: 1389 ident: bib0685 article-title: Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s publication-title: Eur J Cancer – reference: World Health Organisation. WHO Report on the Global Tobacco Epidemic, Country profile: Malawi Web site. – volume: 70 start-page: 458 year: 2016 end-page: 466 ident: bib0505 article-title: The role of tobacco smoke in bladder and kidney carcinogenesis: A comparison of exposures and meta-analysis of incidence and mortality risks publication-title: Eur Urol – reference: UK, England, Office for National Statistics Web site. – volume: 82 start-page: 904 year: 2004 end-page: 913 ident: bib0695 article-title: ICD coding changes and discontinuities in trends in cause-specific mortality in six European countries, 1950-99 publication-title: Bull World Health Organ – reference: . – volume: 63 start-page: 4 year: 2013 end-page: 15 ident: bib0660 article-title: ICUD-EAU International Consultation on Bladder Cancer 2012: Screening, diagnosis, and molecular markers publication-title: Eur Urol – volume: 118 start-page: 3030 year: 2006 end-page: 3044 ident: bib0380 article-title: The global health burden of infection-associated cancers in the year 2002 publication-title: Int J Cancer – volume: 19 start-page: 158 year: 2007 end-page: 162 ident: bib0565 article-title: Bilharziasis and bladder cancer: a time trend analysis of 9843 patients publication-title: J Egypt Natl Canc Inst – volume: 218 start-page: 12 year: 2008 end-page: 20 ident: bib0385 article-title: The global burden of urinary bladder cancer publication-title: Scand J Urol Nephrol Suppl – volume: 67 start-page: 15 year: 1981 end-page: 23 ident: bib0525 article-title: Smoking and cancers of bladder and pancreas: risks and temporal trends publication-title: J Natl Cancer Inst – year: 1960 ident: bib0485 article-title: Cancer mortality for selected sites in 24 countries (1950-57) – volume: 30 start-page: 81 year: 2012 end-page: 88 ident: bib0625 article-title: Disparities in bladder cancer publication-title: Urol Oncol – year: 2015 ident: bib0540 article-title: The tobacco atlas – volume: 22 start-page: 623 year: 2013 end-page: 630 ident: bib0610 article-title: Drinking water arsenic in northern chile: high cancer risks 40 years after exposure cessation publication-title: Cancer Epidemiol Biomarkers Prev – volume: 64 start-page: 639 year: 2013 end-page: 653 ident: bib0675 article-title: EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: Update 2013 publication-title: Eur Urol – reference: Cancer incidence in five continents, Vol. I–X. International Agency for Research on Cancer Web site. – reference: Cancer incidence in five continents, CI5plus. IARC CancerBase No. 9. International Agency for Research on Cancer Web site. – reference: Dimitrova N, Vukov M, Valerianova Z. Report cancer incidence in Bulgaria 2011. Sofia, Bulgaria: Bulgarian National Cancer Registry; 2013. – volume: 107 start-page: S3 year: 2012 end-page: S7 ident: bib0595 article-title: Occupational cancer burden in Great Britain publication-title: Br J Cancer – volume: 28 start-page: 3670 year: 2009 ident: 10.1016/j.eururo.2016.06.010_bib0490 article-title: Estimating average annual per cent change in trend analysis publication-title: Stat Med doi: 10.1002/sim.3733 – volume: 78 start-page: 258 year: 2014 ident: 10.1016/j.eururo.2016.06.010_bib0650 article-title: Thiazolidinediones and associated risk of bladder cancer: A systematic review and meta-analysis publication-title: Br J Clin Pharmacol doi: 10.1111/bcp.12306 – volume: 120 start-page: 86 year: 2014 ident: 10.1016/j.eururo.2016.06.010_bib0700 article-title: Trends in stage-specific incidence rates for urothelial carcinoma of the bladder in the United States: 1988-2006 publication-title: Cancer doi: 10.1002/cncr.28397 – volume: 311 start-page: 183 year: 2014 ident: 10.1016/j.eururo.2016.06.010_bib0375 article-title: Smoking prevalence and cigarette consumption in 187 countries, 1980-2012 publication-title: JAMA doi: 10.1001/jama.2013.284692 – volume: 63 start-page: 4 year: 2013 ident: 10.1016/j.eururo.2016.06.010_bib0660 article-title: ICUD-EAU International Consultation on Bladder Cancer 2012: Screening, diagnosis, and molecular markers publication-title: Eur Urol doi: 10.1016/j.eururo.2012.09.057 – volume: 118 start-page: 3030 year: 2006 ident: 10.1016/j.eururo.2016.06.010_bib0380 article-title: The global health burden of infection-associated cancers in the year 2002 publication-title: Int J Cancer doi: 10.1002/ijc.21731 – ident: 10.1016/j.eururo.2016.06.010_bib0465 – volume: 137 start-page: 2060 year: 2015 ident: 10.1016/j.eururo.2016.06.010_bib0395 article-title: Cancer incidence in five continents: Inclusion criteria, highlights from Volume X and the global status of cancer registration publication-title: Int J Cancer doi: 10.1002/ijc.29670 – ident: 10.1016/j.eururo.2016.06.010_bib0570 – volume: X year: 2013 ident: 10.1016/j.eururo.2016.06.010_bib0400 – volume: 22 start-page: 623 year: 2013 ident: 10.1016/j.eururo.2016.06.010_bib0610 article-title: Drinking water arsenic in northern chile: high cancer risks 40 years after exposure cessation publication-title: Cancer Epidemiol Biomarkers Prev doi: 10.1158/1055-9965.EPI-12-1190 – volume: 63 start-page: 1049 year: 2013 ident: 10.1016/j.eururo.2016.06.010_bib0655 article-title: Screening for bladder cancer: rationale, limitations, whom to target, and perspectives publication-title: Eur Urol doi: 10.1016/j.eururo.2012.12.062 – volume: 20 start-page: 1397 year: 2015 ident: 10.1016/j.eururo.2016.06.010_bib0615 article-title: Bladder cancer risk from the perspective of genetic polymorphisms in the carcinogen metabolising enzymes publication-title: J BUON – volume: 122 start-page: 661 year: 2014 ident: 10.1016/j.eururo.2016.06.010_bib0590 article-title: Tetrachloroethylene exposure and bladder cancer risk: a meta-analysis of dry-cleaning-worker studies publication-title: Environ Health Perspect doi: 10.1289/ehp.1307055 – volume: 94 start-page: 174 year: 2016 ident: 10.1016/j.eururo.2016.06.010_bib0720 article-title: An assessment of GLOBOCAN methods for deriving national estimates of cancer incidence publication-title: Bull World Health Organ doi: 10.2471/BLT.15.164384 – volume: 64 start-page: 639 year: 2013 ident: 10.1016/j.eururo.2016.06.010_bib0675 article-title: EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: Update 2013 publication-title: Eur Urol doi: 10.1016/j.eururo.2013.06.003 – volume: 58 start-page: 493 year: 2015 ident: 10.1016/j.eururo.2016.06.010_bib0645 article-title: Pioglitazone and bladder cancer risk: a multipopulation pooled, cumulative exposure analysis publication-title: Diabetologia doi: 10.1007/s00125-014-3456-9 – ident: 10.1016/j.eururo.2016.06.010_bib0455 – volume: 107 start-page: S3 issue: Suppl 1 year: 2012 ident: 10.1016/j.eururo.2016.06.010_bib0595 article-title: Occupational cancer burden in Great Britain publication-title: Br J Cancer doi: 10.1038/bjc.2012.112 – volume: 218 start-page: 12 year: 2008 ident: 10.1016/j.eururo.2016.06.010_bib0385 article-title: The global burden of urinary bladder cancer publication-title: Scand J Urol Nephrol Suppl doi: 10.1080/03008880802285032 – ident: 10.1016/j.eururo.2016.06.010_bib0495 – ident: 10.1016/j.eururo.2016.06.010_bib0365 – ident: 10.1016/j.eururo.2016.06.010_bib0390 – volume: 30 start-page: 81 year: 2012 ident: 10.1016/j.eururo.2016.06.010_bib0625 article-title: Disparities in bladder cancer publication-title: Urol Oncol doi: 10.1016/j.urolonc.2011.08.011 – volume: 7 start-page: 570 year: 2014 ident: 10.1016/j.eururo.2016.06.010_bib0580 article-title: Schistosomiasis in Malawi: A systematic review publication-title: Parasit Vectors doi: 10.1186/s13071-014-0570-y – volume: 63 start-page: 45 year: 2013 ident: 10.1016/j.eururo.2016.06.010_bib0680 article-title: ICUD-EAU International Consultation on Bladder Cancer 2012: Radical cystectomy and bladder preservation for muscle-invasive urothelial carcinoma of the bladder publication-title: Eur Urol doi: 10.1016/j.eururo.2012.08.009 – ident: 10.1016/j.eururo.2016.06.010_bib0500 – volume: 136 start-page: E359 year: 2015 ident: 10.1016/j.eururo.2016.06.010_bib0475 article-title: Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 publication-title: Int J Cancer doi: 10.1002/ijc.29210 – ident: 10.1016/j.eururo.2016.06.010_bib0405 – volume: 19 start-page: 158 year: 2007 ident: 10.1016/j.eururo.2016.06.010_bib0565 article-title: Bilharziasis and bladder cancer: a time trend analysis of 9843 patients publication-title: J Egypt Natl Canc Inst – ident: 10.1016/j.eururo.2016.06.010_bib0630 – ident: 10.1016/j.eururo.2016.06.010_bib0705 – ident: 10.1016/j.eururo.2016.06.010_bib0460 – volume: 21 issue: Suppl 3 year: 2010 ident: 10.1016/j.eururo.2016.06.010_bib0535 article-title: Trends in principal cancer risk factors in Spain publication-title: Ann Oncol – volume: 69 start-page: 438 year: 2016 ident: 10.1016/j.eururo.2016.06.010_bib0670 article-title: Economic burden of bladder cancer across the European Union publication-title: Eur Urol doi: 10.1016/j.eururo.2015.10.024 – volume: 79 start-page: 379 year: 2012 ident: 10.1016/j.eururo.2016.06.010_bib0555 article-title: Changing patterns (age, incidence, and pathologic types) of schistosoma-associated bladder cancer in Egypt in the past decade publication-title: Urology doi: 10.1016/j.urology.2011.08.072 – ident: 10.1016/j.eururo.2016.06.010_bib0450 – volume: 19 start-page: 421 year: 2008 ident: 10.1016/j.eururo.2016.06.010_bib0560 article-title: The changing patterns of bladder cancer in Egypt over the past 26 years publication-title: Cancer Causes Control doi: 10.1007/s10552-007-9104-7 – volume: 306 start-page: 737 year: 2011 ident: 10.1016/j.eururo.2016.06.010_bib0510 article-title: Association between smoking and risk of bladder cancer among men and women publication-title: JAMA doi: 10.1001/jama.2011.1142 – volume: 14 start-page: 807 year: 2013 ident: 10.1016/j.eururo.2016.06.010_bib0635 article-title: Carcinogenicity of some drugs and herbal products publication-title: Lancet Oncol doi: 10.1016/S1470-2045(13)70329-2 – volume: 82 start-page: 904 year: 2004 ident: 10.1016/j.eururo.2016.06.010_bib0695 article-title: ICD coding changes and discontinuities in trends in cause-specific mortality in six European countries, 1950-99 publication-title: Bull World Health Organ – volume: 103 start-page: 1827 year: 2011 ident: 10.1016/j.eururo.2016.06.010_bib0585 article-title: Preventable exposures associated with human cancers publication-title: J Natl Cancer Inst doi: 10.1093/jnci/djr483 – volume: 25 start-page: 188 year: 2015 ident: 10.1016/j.eururo.2016.06.010_bib0600 article-title: The proportion of cancer attributable to occupational exposures publication-title: Ann Epidemiol doi: 10.1016/j.annepidem.2014.11.009 – volume: 99 start-page: 920 year: 2007 ident: 10.1016/j.eururo.2016.06.010_bib0605 article-title: Fifty-year study of lung and bladder cancer mortality in Chile related to arsenic in drinking water publication-title: J Natl Cancer Inst doi: 10.1093/jnci/djm004 – ident: 10.1016/j.eururo.2016.06.010_bib0530 – ident: 10.1016/j.eururo.2016.06.010_bib0440 – volume: 314 start-page: 265 year: 2015 ident: 10.1016/j.eururo.2016.06.010_bib0640 article-title: Pioglitazone use and risk of bladder cancer and other common cancers in persons with diabetes publication-title: JAMA doi: 10.1001/jama.2015.7996 – ident: 10.1016/j.eururo.2016.06.010_bib0425 – volume: 30 start-page: 4550 year: 2012 ident: 10.1016/j.eururo.2016.06.010_bib0520 article-title: Impact of cigarette smoking on cancer risk in the European prospective investigation into cancer and nutrition study publication-title: J Clin Oncol doi: 10.1200/JCO.2011.41.0183 – year: 2015 ident: 10.1016/j.eururo.2016.06.010_bib0540 – volume: 51 start-page: 2217 year: 2015 ident: 10.1016/j.eururo.2016.06.010_bib0665 article-title: Urinary tract cancer survival in Europe 1999–2007: Results of the population-based study EUROCARE-5 publication-title: Eur J Cancer doi: 10.1016/j.ejca.2015.07.028 – ident: 10.1016/j.eururo.2016.06.010_bib0415 – ident: 10.1016/j.eururo.2016.06.010_bib0430 – ident: 10.1016/j.eururo.2016.06.010_bib0470 – volume: 6 start-page: 411 year: 2006 ident: 10.1016/j.eururo.2016.06.010_bib0545 article-title: Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk publication-title: Lancet Infect Dis doi: 10.1016/S1473-3099(06)70521-7 – ident: 10.1016/j.eururo.2016.06.010_bib0420 – volume: 14 start-page: 406 year: 2014 ident: 10.1016/j.eururo.2016.06.010_bib0515 article-title: Attributable fraction of tobacco smoking on cancer using population-based nationwide cancer incidence and mortality data in Korea publication-title: BMC Cancer doi: 10.1186/1471-2407-14-406 – volume: 67 start-page: 15 year: 1981 ident: 10.1016/j.eururo.2016.06.010_bib0525 article-title: Smoking and cancers of bladder and pancreas: risks and temporal trends publication-title: J Natl Cancer Inst – volume: 63 start-page: 234 year: 2013 ident: 10.1016/j.eururo.2016.06.010_bib0370 article-title: Epidemiology and risk factors of urothelial bladder cancer publication-title: Eur Urol doi: 10.1016/j.eururo.2012.07.033 – volume: 22 start-page: 2055 year: 2013 ident: 10.1016/j.eururo.2016.06.010_bib0620 article-title: N-acetyltransferase 2 phenotype, occupation, and bladder cancer risk: results from the EPIC cohort publication-title: Cancer Epidemiol Biomarkers Prev doi: 10.1158/1055-9965.EPI-13-0119-T – volume: 70 start-page: 458 year: 2016 ident: 10.1016/j.eururo.2016.06.010_bib0505 article-title: The role of tobacco smoke in bladder and kidney carcinogenesis: A comparison of exposures and meta-analysis of incidence and mortality risks publication-title: Eur Urol doi: 10.1016/j.eururo.2015.06.042 – ident: 10.1016/j.eururo.2016.06.010_bib0710 doi: 10.1097/00008469-200508000-00002 – ident: 10.1016/j.eururo.2016.06.010_bib0480 – ident: 10.1016/j.eururo.2016.06.010_bib0575 – ident: 10.1016/j.eururo.2016.06.010_bib0445 – ident: 10.1016/j.eururo.2016.06.010_bib0410 – volume: 101 start-page: 267 year: 2008 ident: 10.1016/j.eururo.2016.06.010_bib0690 article-title: Why has the survival of patients with bladder cancer not improved? publication-title: BJU Int doi: 10.1111/j.1464-410X.2007.07308.x – volume: 44 start-page: 1345 year: 2008 ident: 10.1016/j.eururo.2016.06.010_bib0685 article-title: Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s publication-title: Eur J Cancer doi: 10.1016/j.ejca.2007.12.015 – volume: 9 start-page: 683 year: 2008 ident: 10.1016/j.eururo.2016.06.010_bib0550 article-title: Part I: Cancer in indigenous Africans—burden, distribution, and trends publication-title: Lancet Oncol doi: 10.1016/S1470-2045(08)70175-X – ident: 10.1016/j.eururo.2016.06.010_bib0435 – year: 1960 ident: 10.1016/j.eururo.2016.06.010_bib0485 – year: 2014 ident: 10.1016/j.eururo.2016.06.010_bib0715 – reference: 27417034 - Eur Urol. 2017 Jan;71(1):109-110. doi: 10.1016/j.eururo.2016.06.040.
SSID	ssj0003593
Score	2.6955001
SecondaryResourceType	review_article
Snippet	Bladder cancer has become a common cancer globally, with an estimated 430 000 new cases diagnosed in 2012. We examine the most recent global bladder cancer... Abstract Context Bladder cancer has become a common cancer globally, with an estimated 430 000 new cases diagnosed in 2012. Objective We examine the most... CONTEXTBladder cancer has become a common cancer globally, with an estimated 430 000 new cases diagnosed in 2012.OBJECTIVEWe examine the most recent global...
SourceID	proquest pubmed crossref elsevier
SourceType	Aggregation Database Index Database Enrichment Source Publisher
StartPage	96
SubjectTerms	Bladder Cancer Female Global Health - statistics & numerical data Global Health - trends Humans Incidence Internationality Male Mortality Registries Risk Factors Smoking - adverse effects Smoking - epidemiology Statistics Urinary Bladder Neoplasms - epidemiology Urinary Bladder Neoplasms - etiology Urinary Bladder Neoplasms - mortality Urology
Title	Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends
URI	https://www.clinicalkey.com/#!/content/1-s2.0-S0302283816302809 https://www.clinicalkey.es/playcontent/1-s2.0-S0302283816302809 https://dx.doi.org/10.1016/j.eururo.2016.06.010 https://www.ncbi.nlm.nih.gov/pubmed/27370177 https://www.proquest.com/docview/1826714525
Volume	71
WOSCitedRecordID	wos000390564400034&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVESC databaseName: Elsevier SD Freedom Collection Journals 2021 customDbUrl: eissn: 1873-7560 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0003593 issn: 0302-2838 databaseCode: AIEXJ dateStart: 20020101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1ba9swFBZpOsZexu7LLsWDsZdg8F3S3rKSsm5ZOmgKYS9ClmRYCE7qpGl__s6xZC-lLc0e9mIHY0VY59O56VwI-ZhkWMZchT5LufYTmRV-zlLlFyYpQh0bmWd1ovCIjsdsOuU_O51NkwuzmdOyZFdXfPlfSQ3PgNiYOvsP5G7_FB7AbyA6XIHscN2J8F_myEyq_iHSs0IGYPuG2pCKWtvGTgB1Rrqt-N8_2SDHMJcuWxEDNvs2WPZWxz3ct33xA2xDXAcFnBoQilindctLPZe2J7JUKIFah87CVLMFaMuysog8Xkk8Amlh9quU1pEwgCWzHb4b50RIt5wTxjJURmOfprZnQMNxbdOVa8iy7JNnW4I4rAs-3OTx1t0ww8KY8L0YnZfVJVhdeOy1ktrjE3F0NhqJyXA6-bQ897HbGJ7Ku9Yre2Q_oilnXbI_OB5Ov7UyPE553CRa1tGANye7S5G5y1CpFZbJE_LYWRrewCLkKemY8hl5-MPFUjwn3x1QPAsUrwWKByjwWqB89gaehYnXwKR-wcLEszB5Qc6OhpPDr75rreGrhAZrv2AZC2SuMiUZg5sOacg1mP-xzLnKNU8yVhSZNjlu5CBVcVoEkSk0nvOGpohfkm65KM1r4sVGR3nOpdKKJgrU1TSHN3QUSdDlFdc9EjfrJJSrO4_tT-aiCTCcCbu6AldXYJxlGPSI345a2ror97yfNiQQTU4xSEEBoLlnHL1tnFm5Hb0SoVhFIhCnIA2xVBQDAwbDEfj2SKetWi10hzk_NBgRwMzxhE6WZnEBc4GxT0MMNeiRVxY87deDnUFhh9E3O4x-Sx793Y3vSHddXZj35IHarH-vqgOyR6fswEH-DyRYzpw
linkProvider	Elsevier
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Bladder+Cancer+Incidence+and+Mortality%3A+A+Global+Overview+and+Recent+Trends&rft.jtitle=European+urology&rft.au=Antoni%2C+Sebastien&rft.au=Ferlay%2C+Jacques&rft.au=Soerjomataram%2C+Isabelle&rft.au=Znaor%2C+Ariana&rft.date=2017-01-01&rft.eissn=1873-7560&rft.volume=71&rft.issue=1&rft.spage=96&rft.epage=108&rft_id=info:doi/10.1016%2Fj.eururo.2016.06.010&rft.externalDBID=NO_FULL_TEXT
thumbnail_m	http://cvtisr.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F03022838%2FS0302283816X00115%2Fcov150h.gif